Copy of Order dated 09-OCT-2019 rendered by Chief Justice Crampton concerning the destruction of exhibits tendered into evidence placed on file. Original filed on Court File No. T-967-76

Correspondence between the Registry and the Plaintiff pursuant to the letter sent on December 12, 2018 regarding the return of exhibits. placed on file on 08-JUL-2019

Correspondence between the Registry and the Plaintiff pursuant to the letter sent on December 12, 2018 regarding the return of exhibits. placed on file on 05-JUL-2019

Correspondence between the Registry and the Plaintiff pursuant to the letter sent on December 12, 2018 regarding the return of exhibits. placed on file on 05-JUN-2019

Memorandum to file from J. Lalonde dated 12-DEC-2018 A letter was sent to the parties by CAS Records Management Services on December 12, 2018, inviting them to withdraw their respective exhibits put into evidence. placed on file.

Solicitor's certificate of service on behalf of Jane Caskey confirming service of Doc 139, 140 upon Plaintiff by telecopier on 15-MAY-2014 filed on 15-MAY-2014

Discontinuance on behalf of Plaintiff filed on 15-MAY-2014

Consent on behalf of all parties to the filing of the notice of discontinuance attached hereto as schedule A filed on 15-MAY-2014

Payment of Court fees (ARV#1475) in the amount of #350.00 recd on April 14, 2014 from Goodmans LLP and placed on file on 23-APR-2014

Payment of Court fees (ARV#1478) in the amount of $1,050.00 received from Norton Rose Fullbright Canada LLP on April 10, 2014.

Payment of Court fees (ARV#1477) in the amount of $350.00 received from Sprigings Intellectual Property Law on April 15, 2014.

Payment of Court fees (ARV#1476) in the amount of $350.00 received from Gardiner Roberts LLP on April 7, 2014.

Request for payment of Court Fees (ARV#1478) in the amount of $1050.00 sent to Norton Rose Fullbright Canada LLP placed on file on 21-MAR-2014

Request for payment of Court Fees (ARV#1477) in the amount of $350.00 sent to Sprigings Intellectual Property Law placed on file on 21-MAR-2014

Request for payment of Court Fees (ARV#1476) in the amount of $350.00 sent to Gardiner Roberts LLP placed on file on 21-MAR-2014

Request for payment of Court Fees (ARV#1475) in the amount of $350.00 sent to Goodmans LLP placed on file on 21-MAR-2014

MEMORANDUM to Case Management Judge, Aronovitch, P., from Cynthia Leaver, Ottawa Registry, enclosing copy of DISCONTINUANCE filed 3-MAR-2014 in Federal Court of Appeal file A-397-13 (consolidated with A-398-13) placed on file on 06-MAR-2014

Copy of NOTICE OF DISCONTINUANCE in Federal Court of Appeal file # A-397-13 (consolidated with A-398-13) placed on file on 06-MAR-2014 Original filed on Court File No. A-397-13

List of Exhibits on behalf of all parties received at hearing on 14-FEB-2014

Toronto 13-JAN-2014 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Trial in this action Result of Hearing: Matter adjourned sine die held in Court Senior Usher: Lisa Tirado 13-JAN-2014 Lisa Tirado 14-JAN-2014 Lisa Tirado 15-JAN-2014 Mike Gaida 20-JAN-2014 Mike Gaida 21-JAN-2014 Mike Gaida 23-JAN-2014 Mike Gaida 24-JAN-2014 Greg Nevin 27-JAN-2014 Greg Nevin 28-JAN-2014 Joe Mischuk 29-JAN-2014 Joe Mischuk 30-JAN-2014 Joe Mischuk 31-JAN-2014 Frank Kurina 03-FEB-2014 Noel Nation 04-FEB-2014 Frank Kurina 05-FEB-2014 Frank Kurina 06-FEB-2014 Lisa Tirado 10-FEB-2014 Duration per day: 13-JAN-2014 from 09:35 to 04:10 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 14-JAN-2014 from 09:30 to 02:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 15-JAN-2014 from 09:30 to 12:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 20-JAN-2014 from 09:30 to 12:10 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 21-JAN-2014 from 09:28 to 04:20 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 23-JAN-2014 from 09:28 to 11:45 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 24-JAN-2014 from 09:32 to 11:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 27-JAN-2014 from 09:30 to 11:25 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 28-JAN-2014 from 09:30 to 10:25 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 29-JAN-2014 from 09:30 to 04:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Shirley Aciro 30-JAN-2014 from 09:30 to 05:30 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 31-JAN-2014 from 08:58 to 10:19 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 03-FEB-2014 from 09:28 to 05:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 04-FEB-2014 from 09:28 to 04:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 05-FEB-2014 from 09:29 to 05:02 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 06-FEB-2014 from 09:27 to 14:57 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 10-FEB-2014 from 09:30 to 14:33 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith Total Duration: 17d Appearances: Mr. Harry Radomski 416-979-2211 representing Plaintiff Mr. Jerry Topolski 416-979-2211 representing Plaintiff Mr. David Scrimger 416-979-2211 representing Plaintiff Ms. Jenene Roberts 416-979-2211 representing Plaintiff Mr. Ken Crofoot 416-979-2211 representing Plaintiff Ms. Carol Hitchman 416-865-6600 representing Plaintiff Ms Alisse Houweling 416-865-6600 representing Plaintiff Mr. Warren Sprigings 416-777-0888 representing Plaintiff Mr. Christopher Tan 416-777-0888 representing Plaintiff Mr. Patrick Kierans 416-216-4000 representing Defendant Ms. Jordan Sanft 416-216-4000 representing Defendant Mr. Daniel Daniele 416-216-4000 representing Defendant Ms. Jane Caskey 416-216-4000 representing Defendant Ms. Amy Grenon 416-216-4000 representing Defendant Exhibits filed at hearing: A-1-A-56 APO-1 to APO 3 GSK- 1 to GSK - 22 Witness(es) on behalf of Plaintiff Dr. Robert Langer Cambridge MA, USA on behalf of Plaintiff Dr. Jonathan Dordick Schenecyady, NY, USA on behalf of Plaintiff Dr. Stephen Hanessian, Beaconsfield, QC Canada on behalf of Plaintiff Dr. Clyde S. Crumpacker Boston MA, USA on behalf of Plaintiff Dr. Michael Mayersohn Marana Arizona, USA on behalf of Plaintiff Dr. Paul A. Laskar Napa, CA USA on behalf of Defendant Dr. Hans Maag Murnau, Germany on behalf of Defendant Dr. Stephen Graham Davies Oxford, UK on behalf of Defendant Dr. Jennifer Dressman Frankfurt, Germany on behalf of Defendant Dr. Barbara Romanowski Edmonton, AB Cana

Covering letter from Plaintiff dated 20-JAN-2014 concerning Issuance of 6 Subpoenas(in blank) and Requests for Writ(s) of Subpoena placed on file on 20-JAN-2014

Writ of Subpoena Ad Testificandum issued on 20-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 20-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 20-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 20-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 20-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 20-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 20-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 20-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 20-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 20-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 20-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 20-JAN-2014 Tariff any other proceeding - $30.00

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 24-JAN-2014 Tariff any other proceeding - $30.00

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 24-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum TO: Glenn Monteith pursuant to the Order of Justice Manson dated 10-JAN-2014 issued on 24-JAN-2014 cc filed

Writ of Subpoena Ad Testificandum to: Kelly Uyeno pursuant to the Order of Justice Manson dated 10-JAN-2014 issued on 24-JAN-2014 cc filed

Acknowledgment of Receipt received from Defendant with respect to DOC. 120 AND ENTRY ON JAN 23-2014-CORRECTED PAGES. placed on file on 24-JAN-2014

Corrections to page(s) 2 3 4 5 6 7 8 9 of the Reasons of The Honourable Mr. Justice Manson that were dated 10-JAN-2014 received on 23-JAN-2014 Corrected pages sent to parties

Solicitor's certificate of service on behalf of Jesse Todres confirming service of doc. 121 upon Plaintiff by telecopier on 16-JAN-2014 filed on 16-JAN-2014

Notice Under the Canada Evidence Act on behalf of Defendant filed on 16-JAN-2014

Letter from Plaintiff dated 15-JAN-2014 regarding Pharmascience's expert reports relating to damages claim by GSK as follows: Ms. Kim Van Wart(20-may-2013), Mr. Doug Welsh(21-May-2013), Mr. George Wyatt(21-May-2013), Mr. Kenny Tan(21-may-2013). AFOREMENTIONED REPORTS ATTACHED. received at hearing on 15-JAN-2014

Acknowledgment of Receipt received from Defendant with respect to doc. 120 placed on file on 10-JAN-2014

Order dated 10-JAN-2014 rendered by The Honourable Mr. Justice Manson Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 116 Result: granted Filed on 10-JAN-2014 certified copies sent to parties entered in J. & O. Book, volume 1216 page(s) 197 - 205 Interlocutory Decision

Motion Record containing the following original document(s): 116 117 118 Number of copies received: 3 on behalf of Defendant filed on 10-JAN-2014

Written Representations on behalf of Defendant concerning Motion Doc. No. 116 filed on 10-JAN-2014

Affidavit of Karen Sie sworn on 08-JAN-2014 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 116 filed on 10-JAN-2014

Notice of Motion made ex parte contained within a Motion Record on behalf of Defendant in writing to be dealt with in the Toronto local office for an Order granting leave for the issuance to GSK of subpoenas, in the form attached hereto as Schedule "A"; other relief. filed on 10-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 09-JAN-2014 directing that Upon hearing from counsel at a case management confenence on January 9, 2014 to the stipulations agreed to by the parties, the Trial in the above noted files will now commence on Monday, January 13, 2014 sitting at 9:30 to 5:00 p.m. and until 12:00 p.m. on Fridays. placed on file on 09-JAN-2014 Confirmed in writing to the party(ies)

Ottawa 09-JAN-2014 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss scheduling issued in this file and T-14-09 and T-2101-09 Result of Hearing: The Court directed that the Trial of the matter would commenc on Monday January 13, 2014, commencing at 9:30 a.m. to 5:00 p.m. and until 12:00 on Fridays held by way of Conference Call Duration per day: 09-JAN-2014 from 02:00 to 02:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 30min Appearances: Mr. Sprigings and Mr. Tan 416-777-2273 representing Pharmascience Ms. Hitchman and Ms Houweling 416-865-8259 representing Pharmascience Ms Sanft, Mr. Kierans and Ms Caskey 416-216-4798 representing GSK Mr. Radomski, Mr. Topolski and Mr. Scrimger 416-597-4142 representing Apotex Comments: For full minutes see the minutes in T-14-09 The Court will issue a direction shortly Minutes of Hearing entered in Vol. 895 page(s) 69 - 70 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the amended protective and confidentiality order dated 6-Jan-2014 placed on file on 06-JAN-2014

Protective Order and Confidentiality Order dated 06-JAN-2014 rendered by The Honourable Mr. Justice Manson Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 112 Result: granted Filed on 06-JAN-2014 copies sent to parties entered in J. & O. Book, volume 1215 page(s) 330 - 341 Interlocutory Decision

Acknowledgment of Receipt received from all parties with respect to the amended direction of the Court dated 3-Jan-2014 (ID 594) placed on file on 06-JAN-2014

Acknowledgment of Receipt received from all parties except GSK with respect to the direction of the Court dated 3-Jan-2014 (ID 593) placed on file on 03-JAN-2014

Acknowledgment of Receipt received from all parties with respect to the direction of the Court scheduling a CMC on 3-Jan-2014 at 1:30 p.m. placed on file on 03-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that having considered Ms. Hitchman's correspondence dated January 3, 2014, I amend my direction as follows: Apotex and Pharmascience shall serve and file the written representations for the motion by 2 pm on Thursday, January 9, 2014; GSK shall serve and file its responding written representions for the motion by 2 pm on Thursday, January 16, 2014; The motion will be heard on January 20, 2014 placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that having considered the parties' correspondence dated January 2, 2014, I direct as follows: Apotex and PMS will complete their Motion Record including any affidavit and written argument by January 7, 2014; GSK will serve any responding affidavit by January 9, 2014; Cross-examinations on any affidavit will be completed by January 10, 2014; GSK will serve and file its responding record by January 16, 2014; The motion for leave to file reply evidence report will be heard on January 20, 2014; Accordingly, the case management conference scheduled to take place today at 1:30 p.m. will not proceed placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Letter from Pharmascience in T-2101-09 dated 03-JAN-2014 advising that the parties came to an agreement re: the schedule to perfect the motion for leave and requesting that the Court amend its direction issued earlier today (sent to the trial judge by e-mail on 3-Jan-2014) received on 03-JAN-2014

Acknowledgment of Receipt received from all parties (GSK over the phone) with respect to the direction of the Court dated 2-Jan-2014 placed on file on 02-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that a CMC by TC will take place on 3-Jan-2014 at 1:30 p.m. to discuss the scheduling of the motion for leave placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Letter from GSK dated 02-JAN-2014 in response to Apotex's letter of 2-Jan-2014 and proposing a schedule in the event the Court directs that the motion for leave be heard on 20-Jan-2014 received on 02-JAN-2014

Letter from Apotex dated 02-JAN-2014 advising of issues with hearing the motion for leave on 13-Jan-2014 and proposing a schedule that would make it returnable on 20-Jan-2014 received on 02-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 02-JAN-2014 directing that GSK to serve any responding affidavits to Apotex motion materials filed December 2, 2013 by January 6, 2014; any cross-examinations on the affidavit of all parties, to be conducted by January 8, 2014; GSK to file and serve its responding record by January 9, 2014; any reply and motion to be heard January 13, 2014 placed on file on 02-JAN-2014 Confirmed in writing to the party(ies)

Letter from PMS in T-2101-09 dated 31-DEC-2013 in response to GSK's letter dated 30-Dec-2013 (sent to the Trial Judge on 2-Jan-2014 received on 31-DEC-2013

Letter from GSK dated 30-DEC-2013 suggesting that Apotex and Pharmascience's motion for leave to file reply expert evidence be heard prior to the commencement of Apotex and Pharmascience's evidence on validity and response to infringement and requesting that a timetable be set for perfecting the motion (sent to the Trial Judge on 30-Dec-2013) received on 30-DEC-2013

Copy of a Letter from Plaintiff to Defendant GSK dated 28-NOV-2013 outlining understanding regarding redacted documents received on 28-NOV-2013

Writ of Subpoena Ad Testificandum to: Lucie Robitaille, Chair and CEO, Management Board of Parental Insurance issued on 20-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 20-DEC-2013 Tariff any other proceeding - $30.00

Memorandum to file from Toronto dated 18-DEC-2013 For the complete motion record see Court File T-14-09 placed on file.

Notice of Motion on behalf of Glaxosmithkline Inc. in writing(on consent) to the trial judge, Mr. Justice Manson for An Order varying the Protective Order in Court T-14-09; An Order varying the Further Amended Protective Order and Confidentiality Order pursuant to R.151 in Court file T-2109-09; An Order varying the Amended Confidentiality and Protective Order pursuant to R.151 in Court file T-643-10 filed on 18-DEC-2013 Draft Order\\Judgment received.

Copy of written direction dated 17-DEC-2013 rendered by The Honourable Mr. Justice Manson placed on file. Original filed on Court File No. T-14-09

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 17-DEC-2013 directing that having considered the submissions of counsel concerning my direction on December 10, 2013, paragraph 4 of the draft Direction submitted to the Court on December 13, 2013 should be deleted. While the acknowledgment by GlaxoSmithKline Inc. et al. (GSL) that the third party reports ordered produced are not privileged does not act as a waiver of privilege in respect of any other documents or information not contained in the reports, the direction does not need to, nor should it extend to any such hypothetical documents or information not in issue placed on file on 17-DEC-2013 Confirmed in writing to the party(ies)

Writ of Subpoena Ad Testificandum LUCIE ROBITAILLE, VICE PRESIDENT, INSTITUT NATIONAL d' EXCELLENCE SANTE ET EN SERVICES SOCIAUX, 2535 BOULEVARD LAURIER, 5TH FLOOR, QUEBEC GIV 4M3, QC issued on 17-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 17-DEC-2013 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum directed to VIRGINIA CIROCCO-1820 SHADY CREEK COURT. MISSISSAUGA, ON. L5L 3W2. issued on 17-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 17-DEC-2013 Tariff any other proceeding - $30.00

Letter from Plaintiff dated 16-DEC-2013 providing submissions in response to GSK's re: why par. 4 should not be included in the direction arising out of the CMC held on 10-Dec-2013 received on 16-DEC-2013

Letter from GSK dated 13-DEC-2013 providing a draft direction arising out of the CMC held on 10-Dec-2013 and submissions supporting their position with regards to par. 4 of the draft direction received on 13-DEC-2013

Writ of Subpoena Ad Testificandum BRENT FRASER, DIRECTOR, DRUG PROGRAM SERVICES, ONTARIO PUBLIC DRUG PROGRAM BUREAU, HEPBURN BLOCK, 9TH FLOOR, 80 GROSVENOR ST. TORONTO, ON, M7A 1R3 issued on 16-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 16-DEC-2013 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 13-DEC-2013 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendant filed on 13-DEC-2013 Tariff any other proceeding - $30.00

Covering letter from Defendant dated 10-DEC-2013 concerning Doc. Nos. 97 99 101 103 placed on file on 11-DEC-2013

Memorandum to file from Julie Dulac dated 11-DEC-2013 the Expert Report of Dr. Barbara Romanowski dated 19-Oct-2013 which is also applicable in this file was filed in T-14-09 as doc. 127 placed on file.

Sealed envelope pursuant to the Protective Order dated 29-Jun-2011 on behalf of Defendant purporting to contain the Expert Report of Andrew Tepperman PH.D. dated 18-Oct-2013 and doc. 102 (only 2 copies filed and 1 sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness of Andrew Tepperman PH.D. dated 18_Oct-2013 on behalf of Defendant filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 29-Jun-2011 on behalf of Defendant purporting to contain the Expert Report of Stephen Wilton dated 20-Oct-2013 and doc. 100 (only 2 copies filed and 1 sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness of Stephen Wilton on behalf of Defendant filed on 11-DEC-2013

Sealed envelope pursuant to the Protective Order dated 29-Jun-2011 on behalf of Defendant purporting to contain the Expert Report of Neil Palmer dated 20-Oct-2013 (GSK's Section 8 Damages T-643-10) and doc. 98 (only 2 copies filed and 1 sent directly to trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness Neil Palmer on behalf of Defendant filed on 11-DEC-2013

Memorandum to file from Julie Dulac dated 11-DEC-2013 the Expert Report of Dr. Iain Cockburn dated 3-Dec-2013 (GSK's Infringement Damages T-2101-09) was filed in file T-2101-09 as doc. 164 and sent directly to the trial judge placed on file.

Sealed envelope pursuant to the Protective Order dated 29-Jun-2011 on behalf of Defendant purporting to contain the Expert Report of Ross Hamilton dated 21-Oct-2013 (GSK's Section 8 Damages T-643-10)and doc. 96 (only 2 copies filed and 1 sent directly to trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness Ross Hamilton dated 21-Oct-2013 (GSK's Section 8 Damages T-643-10) on behalf of Plaintiffs filed on 11-DEC-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Nov-2013 placed on file on 28-NOV-2013

Vancouver 04-DEC-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion Doc. No. 84 on behalf of defendant - GlaxoSmithKline Result of Hearing: Matter reserved held in Court Senior Usher: Heather Richards Duration per day: 04-DEC-2013 from 09:10 to 11:35 Courtroom : Courtroom No. 601 - Vancouver Court Registrar: Sandra McPherson Total Duration: 2h25min Appearances: Ms Allyson Whyte-Nowak (Norton Rose Canada LLP) 1.416.216.1899 representing Plaintiff - Glaxosmithkline Inc Court Reporter: Sharon Leeburn All-West Court Reporters Vancouver BC 604.683.4774 04-DEC-2013 Transcript not requested Minutes of Hearing entered in Vol. 893 page(s) 123 - 124 Abstract of Hearing placed on file

Memorandum to file from Julie Dulac dated 11-DEC-2013 one copy of the expert reports of Dr. Clyde S. Crumpacker II and Dr. Robert S. Langer were filed in T-14-09 (docs 122 and 123) and sent directly to the trial judge placed on file.

Ottawa 10-DEC-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the issues with the filing of expert reports and privilege issues and correspondence dated 2-Dec-2013 from GSK Result of Hearing: Direction to follow held in chambers by way of Conference Call Duration per day: 10-DEC-2013 from 12:30 to 12:48 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Harry Radomski, Jerry Topolski and Dave Scrimger 416-597-4142 representing Apotex Jordana Sanft, Jane Caskey, Patrick Kierans and Amy Grenon 416-216-4798 representing GSK Carol Hitchman and Alisse Houweling 416-859-2722/416-865-4010 representing Pharmascience in T-2101-09 and T-643-10 Draft Decision to be submitted by counsel for GSK Minutes of Hearing entered in Vol. 893 page(s) 103 - 104 Abstract of Hearing placed on file

Covering letter from counsel for GSK dated 29-NOV-2013 concerning Doc. No. 94 placed on file on 29-NOV-2013

Solicitor's certificate of service on behalf of Daniel Daniele confirming service of doc. 94 upon all parties by telecopier on 29-NOV-2013 filed on 29-NOV-2013

GSK's Patent Claims Chart filed on 29-NOV-2013

Letter from GSK dated 03-DEC-2013 advising that Apotex intends to dispute the propriety of the redactions to the third party economic studies at the hearing of the motion to amend on 4-Dec-2013, asking that the Court not entertain Apotex's request until proper motion is filed and asking that a schedule for filing of material and hearing date be set received on 03-DEC-2013

Copy of Order dated 06-DEC-2013 rendered by The Honourable Mr. Justice Manson concerning motion doc. 84 placed on file. Original filed on Court File No. T-14-09

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 06-DEC-2013 directing that a case management conference by telephone conference is scheduled to take place on Tuesday December 10, 2013 at 12:30 EST placed on file on 06-DEC-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 06-DEC-2013 requesting a CMC to discuss issues with filing of expert reports and attaching correspondence between the parties on the subject (sent to Mr. Justice Manson by e-mail on 6-Dec-2013) received on 06-DEC-2013

Letter from Apotex dated 02-DEC-2013 in response to GSK's letter dated 2-Dec-2013 received on 02-DEC-2013

Letter from GSK dated 02-DEC-2013 providing a status on the privilege issue and requesting that a direction be issued in advance of the documents being produced (sent to Manson J. by e-mail on 3-Dec-2013) received on 02-DEC-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 28-NOV-2013 directing that if the parties cannot agree on production of the transfer pricing documents by GSK for the years 2005 through 2008, by Friday November 29, 2013, GSK will forward a breif with sufficient particulars to opposing counsel and to Court specifying the origin and recipient of eahc document for which solicitor-client privilege is claimed and the reason for the claim of privilege for each such document. GSK will also supply a copy of each such document, under seal, to the Court only. GSK is to file the brief and documents, in Vancouver, to my attention, no later than noon on December 2, 2013. Counsel for Apotex and PMS shall have until 4:30 pm EST on December 3, 2013, to serve and file any responding brief to GSK's brief, and the matter will be heard by me on December 4, 2013, in Vancouver placed on file on 27-NOV-2013 Confirmed in writing to the party(ies)

Letter from Apotex (plaintiff in T-14-09) dated 27-NOV-2013 advising that Apotex and PMS can confirm that they are able to provide 5 expert reports at this time (sent to Manson J. by e-mail on 28-Nov-2013) received on 27-NOV-2013

Letter from Plaintiff dated 22-NOV-2013 attaching their trial chart received on 22-NOV-2013

Ottawa 27-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss privilege issues raised in GSK's correspondence dated 26-Nov-2013 Result of Hearing: see abstract in T-14-09 held in chambers by way of Conference Call Duration per day: 27-NOV-2013 from 02:30 to 02:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 10min Appearances: Jerry Topolski 416-597-5907 representing Apotex in T-14-09 Jane Caskey and Dan Daniele 416-216-2317 representing GSK Christopher Tan 417-777-2647 representing PMS Minutes of Hearing entered in Vol. 892 page(s) 50 - 51 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the Order of the Court dated 26-Nov-2013 placed on file on 26-NOV-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 21-Nov-2013 placed on file on 21-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 26-NOV-2013 directing that a case management conference by telephone conference will take place on November 27, 2013 at 2:30 p.m. (to discuss the issues raised in GSK's letter dated 26-Nov-2013) placed on file on 26-NOV-2013 Confirmed in writing to the party(ies)

Copy of Order dated 26-NOV-2013 rendered by The Honourable Mr. Justice Manson concerning Motion doc. 89 placed on file. Original filed on Court File No. T-14-09

Letter from GSK dated 26-NOV-2013 seeking a direction of the Court relating to an issue of privilege (sent to Manson J. By e-mail on 26-Nov-2013) received on 26-NOV-2013

Draft Order concerning Motion Doc. No. 89 consented to by all parties received on 25-NOV-2013

Solicitor's certificate of service on behalf of Daniel Danielle confirming service of Doc. No. 92 upon Plaintiff by process server on 22-NOV-2013 filed on 22-NOV-2013

Trial Chart on behalf of the Defendant filed on 22-NOV-2013

Letter from Plaintiff dated 22-NOV-2013 attaching a draft order re: motion doc.89 not consented to by GSK received on 22-NOV-2013

Solicitor's certificate of service on behalf of Christopher Tan confirming service of doc 90 upon Defendant by process server on 22-NOV-2013 filed on 22-NOV-2013

Trial Record on behalf of Plaintiff filed on 22-NOV-2013

Ottawa 21-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the Court's direction dated 19-Nov-2013 requiring the parties to file their expert report prior to trial Result of Hearing: The Court asked for a report by November 29 on what expert reports will be available to the Court when and the reports the parties are sure to rely on would be filed by December 6, 2013. The parties are therefore relieved from having to comply with the November 19th direction held in chambers by way of video conference Duration per day: 21-NOV-2013 from 03:30 to 04:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jerry Topolski and Harry Radomski 416-597-5907 representing Apotex Patrick Kierans, Jordana Sanft, Daniel Daniele and Amy Grenon 416-216-2317 representing GSK Carol Hitchman and Alisse Howeling 416-865-8259 representing Pharmascience in T-2101-09 Christopher Tan 416-777-2647 representing Pharmascience Minutes of Hearing entered in Vol. 891 page(s) 410 - 411 Abstract of Hearing placed on file

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 21-NOV-2013 directing that GSK's motion to amend will be heard in Vancouver on December 4, 2013 at 9:00 a.m. for 1 day. Apotex's and PMS' responding motion record including transcripts of cross-examinations but without written argument will be served and filed, in Vancouver, by noon, on December 2, 2013. Apotex's and PMS' responding written argument will be served and filed electronically at cmt_ottawa@cas-satj.gc.ca by December 2, 2013 placed on file on 21-NOV-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 20-NOV-2013 indicating that the parties are available for the hearing of GSK's motion to amend on December 4 in Vancouver at 9:00 a.m. and suggesting a schedule for the filing of responding material received on 21-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 20-NOV-2013 directing that a case management telephone conference will take place on November 21, 2013 at 3:30 p.m. placed on file on 20-NOV-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 19-NOV-2013 directing that any expert report in chief and in rebuttal served between the parties to date shall be submitted for filing with the Court by November 27th. Any expert report which is due to be served prior to trial shall be submitted for filing with the Court on the date it is due to be served placed on file on 19-NOV-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 20-NOV-2013 requesting a CMC with Manson J. to discuss certain issues in relation to the direction dated 19-Nov-2013 received on 20-NOV-2013

Toronto 12-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion Doc. No. 89 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Joe Mischuk Duration per day: 12-NOV-2013 from 09:35 to 15:31 Courtroom : Courtroom No. 4-B - Toronto Court Registrar: Heather Michaud Total Duration: 5h 56min Appearances: Christopher G. T. Tan 416-777-2647 representing Plaintiff Warren Sprigings 416-777-2273 representing Plaintiff Jane E. Caskey 416-216-1899 representing Defendant Amy Grenon 416-216-1931 representing Defendant Draft Decision to be submitted by the parties Comments: Laptop Z006122 was used to record this hearing. Heard together with T-14-09 and T-2101-09. Minutes of Hearing entered in Vol. 890 page(s) 329 - 345 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 5-Nov-2013 placed on file on 05-NOV-2013

Copy of Order dated 08-NOV-2013 rendered by The Honourable Mr. Justice Manson concerning CMC held 8-Oct-2013 and 11-Oct-2013 setting a timetable placed on file. Original filed on Court File No. T-14-09

Memorandum to file from Julie Dulac dated 08-NOV-2013 the material filed in support of motion doc. 89 can be found in file T-14-09 (doc. 99 and Authorities) placed on file.

Sealed envelope purporting to contain the Notice of Motion on behalf of Apotex (in T-14-09) and Pharmascience Inc. et al. returnable at Special Sitting in Toronto on 12-NOV-2013 to begin at 09:30 for an Order compelling the representatives of the Responding Parties, GlaxoSmithKline Inc... to provide answers to questions undertaken to be answered from the written questions of Pharmascience and Apotex by November 15, 2013... filed on 08-NOV-2013

Solicitor's certificate of service on behalf of Amy Grenon confirming service of Doc. 87 and Book of Authorities upon Plaintiff by personal service on 05-NOV-2013 filed on 05-NOV-2013

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 05-NOV-2013 Sent directly to Presiding Judge

****** CANCELLED ****** Motion Record containing the following original document(s): 84 85 86 Number of copies received: 2 on behalf of Defendant filed on 05-NOV-2013

****** CANCELLED ****** Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 84 filed on 05-NOV-2013

****** CANCELLED ****** Affidavit of Norman Vojir sworn on 05-NOV-2013 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 84 with Exhibits A (confidential) filed on 05-NOV-2013

Notice of Motion contained within a Motion Record on behalf of Defendant returnable (but no hearing date indicated at this time) for an Order permitting GlaxoSmithKline to serve and file the Second Further Amended Statement of Defence and Counterclaim and the Third Further Amended Statement of Claim, adding GlaxoSmithKline Intellectual Property (No. 2) Limited as Plaintiff by Counterclaim in file T-14-09 and as Plaintiff in file T-2101-09, and amending the style of cause in T-14-09 and T-2101-09 filed on 05-NOV-2013

Draft Order concerning outcome of CMC of 11-Oct-2013 &amalgamation of existing timetables consented to by all parties (sent to CMJ on 5-Nov-2013) received on 05-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 05-NOV-2013 directing that by November 6, 2013, the parties are to provide the draft order regarding the outcome of the case management conference held on October 11, 2013, which was agreed would also include all outstanding timelines set be previous Orders or, by the same date, provide their availability on November 7 and 8 for a case management conference to discuss the issues preventing the parties from producing the draft order placed on file on 05-NOV-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 21-OCT-2013 advising that they need a few more days to provide a draft order re: the CMC of 11-Oct-2013 received on 21-OCT-2013

Letter from GSK dated 18-OCT-2013 advising that they need until 21-Oct-2013 to provide a draft order re: the 11-Oct-2013 CMC received on 18-OCT-2013

Ottawa 11-OCT-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss amendments to schedule Result of Hearing: The parties will provide a draft order which will set out all remaining timelines including timelines set by previous orders by next week held in chambers by way of Conference Call Duration per day: 11-OCT-2013 from 11:30 to 12:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jerry Topolski and Davis Scrimger 416-597-5907 representing Apotex Jordanna Sanft and Jane Caskey 416-216-4000 representing GSK Carol Hitchman 416-865-8259 representing Pharmascience in T-2101-09 Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Comments: November 12, 2013 has been set aside for the hearing of refusals motions re: third round discovery Minutes of Hearing entered in Vol. 888 page(s) 395 - 396 Abstract of Hearing placed on file

Letter from Apotex dated 10-OCT-2013 providing a proposed schedule to be discussed at the CMC on 11-Oct-2013 (sent to the CMJ on 11-Oct-2013) received on 11-OCT-2013

Letter from GSK dated 09-OCT-2013 advising that the parties are discussing alternative dates for discovery of GSK's representative (brought to the CMJ's attention on 10-Oct-2013) received on 10-OCT-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 08-OCT-2013 directing that a case management conference by telephone conference will take place on 11-Oct-2013 at 11:30 a.m. to discuss the required amendments to the timetable placed on file on 08-OCT-2013 Confirmed in writing to the party(ies)

Memorandum to file from Julie Dulac dated 08-OCT-2013 Briefs were submitted by the parties for the purpose of the CMC scheduled on 8-Oct-2013. Only one copy was provided and they were filed in T-2101-09 placed on file.

Ottawa 08-OCT-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the scope the third round discovery Result of Hearing: see abstract in T-2101-09 held in Court Senior Usher: S. Young Duration per day: 08-OCT-2013 from 09:30 to 11:55 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 2h30min Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Apotex Patrick Kierans and Jane Caskey 416-216-4000 representing GSK Warren Sprigings and Christopher Tan 416-777-2647 representing Pharmascience Minutes of Hearing entered in Vol. 888 page(s) 324 - 325 Abstract of Hearing placed on file

Letter from GSK dated 07-OCT-2013 providing a status report received on 08-OCT-2013

Acknowledgment of Receipt received from both parties with respect to the instructions of the Court dated 2-Oct-2013 placed on file on 02-OCT-2013

Letter from counsel for Apotex dated 03-OCT-2013 advising that since there was already a TMC in this matter and another one is scheduled on 08-Oct-2013, they assume that the requirement in par 1(e) of the Order of 24-Apr-2013 is no longer required. (I contacted counsel by e-mail and advised them that Mr. Topolski's assumption is correct; no need for a request for TMC) received on 03-OCT-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 02-OCT-2013 directing that (further to Apotex's correspondence dated 1-Oct-2013) the timetable is fine but two notes: final arguments must be finished b march 20; if this is an issue, we will have to start the trial earlier; otherwise, if counsel are agreed, we'll reserve the January 10th date as the start date. Counsel are to confirm agreement and a direction will issue accordingly placed on file on 02-OCT-2013 Confirmed in writing to the party(ies)

Letter from Apotex on behalf of all parties dated 01-OCT-2013 advising the Trial Judge that the parties have reached a resolution with respect to the order of presentation of the various issues raised in the actions and the timing for trial(sent to the Trial Judge by e-mail on 2-Oct-2013) received on 01-OCT-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 1-Oct-2013 placed on file on 01-OCT-2013

Copy of the direction dated 01-OCT-2013 rendered by The Honourable Mr. Justice Manson placed on file. Original filed on Court File No. T-2101-09

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Sep-2013 placed on file on 27-SEP-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 27-SEP-2013 directing that GSK's request that the third round discovery scheduled to take place on October 2 and 3, 2013 and the case management conference scheduled September 30 be adjourned is granted. The fact that there are some 4000 questions raised in what is supposed to be a limited third round of discovery is unacceptable. Proportionality is completely missing. I direct that Pharmascience and Apotex reconsider and limit the questions to be answered. By 5:00 p.m. September 30, 2013, the parties will advise when the re-attendance for discovery can be held during the week of October 14, 2013. By the same date, the parties will provide their availability for an in person case management conference, in Ottawa, during the week of October 7, 2013 (except October 10, 2013) placed on file on 27-SEP-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 27-SEP-2013 requesting a direction adjourning the discovery scheduled to take place on October 2 and 3, 2013 and the CMC by TC scheduled on 30-Sep-2013 and re-scheduling it as an in person CMC received on 27-SEP-2013

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 25-Sep-2013 placed on file on 25-SEP-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 25-SEP-2013 directing that a case management teleconference will take place on September 30, 3013 at 10:00 a.m. to discuss the issues raised in the parties' correspondence dated September 23 and 24, 2013 placed on file on 25-SEP-2013

Communication to the Court from the Registry dated 25-SEP-2013 re: the parties' correspondence dated September 23 and 24, 2013

Letter from Pharmascience dated 24-SEP-2013 submitting that a CMC on issues with discoveries at this time is premature received on 24-SEP-2013

Letter from GSK dated 23-SEP-2013 advising of issues with respect to further examinations for discovery and requesting a CMC to address these issues received on 23-SEP-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 18-Sep-2013 placed on file on 20-SEP-2013

Written directions received from the Court: The Honourable Mr. Justice Manson dated 18-SEP-2013 directing that 1. All parties will serve and file their amended pleadings by September 6, 2013; 2. Counsel for Pharmascience et al. and Apotex will deliver to counsel for GSK et al. questions that will be asked of Mr. Vojir by September 19, 2013; 3. Counsel for GSK et al. will make Mr. Vojir available to be examined for 2 days during the week of September 30, 2013, subject to his availablility; 4. All parties will serve and file trial charts by November 8 2013; 5. All parties will serve and file claims charts by November 29, 2013; and 6. The Court has reserved on the issue of the order of trial issues until after the filing of the trial charts, and will issue an order regarding this matter during the week of November 11, 2013. placed on file on 18-SEP-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 16-SEP-2013 re: (to Manson J. by e-mail) draft direction and trial management conference minutes

Minutes of trial management conference received on 13-SEP-2013

Draft direction concerning trial mangement conference received on 13-SEP-2013

Toronto 03-SEP-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Trial Management Conference Result of Hearing: On consent of counsel for the parties, the Court determines the following steps to be complete: 1. Further Amended Pleading to be served and filed by September 9, 2013. 2. Apotex and Pharmascience shall provide to GSK their written questions for discovery by September 19/13. 3. Cross- examinations of the GSK representative shall be conducted during the week of September 30/13. 4. Each party shall file a Trial scheduled by November 8/13. 5. Claim Charts shall be filed by November 29/13. held ADR Senior Usher: Anne Brzuchalski Duration per day: 03-SEP-2013 from 03:00 to 04:00 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Mary Sansone Total Duration: 1h Appearances: Carol Hitchman, Alisse Houweling, Amit Patel 416 865-8259 representing Plaintiff Patrick Kierans, Jane Caskey, Jordana Sanft 416 216-4000 representing Defendant Comments: Heard jointly together with T-14-09 and T-2101-09 Minutes of Hearing entered in Vol. 885 page(s) 469 - 471 Abstract of Hearing placed on file

Acknowledgment of Receipt received from GSK and PMS with respect to Madam Aronovitch's direction dated 21-Aug-2013 placed on file on 21-AUG-2013

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 21-AUG-2013 directing that the mediation that was scheduled to be heard November 18-21 has been rescheduled to November 13-15. placed on file on 21-AUG-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 21-AUG-2013 directing that as there is no agreement between the parties and a Direction has not issued, parties are to refer the matters in dispute to Justice Manson. The contentious issues could only be dealt with by Direction, if with the guidance I provided parties were able to come to some agreement. Failing agreement, the disputes will likely require a motion placed on file on 21-AUG-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 20-AUG-2013 advising that the parties are unable to agree on the oral direction given by Madam Aronovitch at the CMC on 6-Aug-2013 (sent to Madam Aronovitch on 21-Aug-2013) received on 21-AUG-2013

Memorandum to file from Julie Dulac dated 16-AUG-2013 the parties were advised that they may submit their proposed timetable by 20-Aug-2013 placed on file.

Letter from GSK dated 15-AUG-2013 requesting an extension of time to submit a schedule for the service and filing of the amended pleadings and written discovery received on 15-AUG-2013

Acknowledgment of Receipt received from all parties with respect to the direction of Manson J. dated 9-Aug-2013 placed on file on 09-AUG-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 09-AUG-2013 directing that a CMC/Trial Management Conference is scheduled, in person, in Toronto on September 3, 2013 at 3:00 p.m. placed on file on 09-AUG-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 09-AUG-2013 re: (to Manson J. by e-mail) GSK's letter dated 8-Aug-2013

Letter from GSK dated 08-AUG-2013 providing the availability of parties for a CMC/trial management conference with Mr. Justice Manson received on 08-AUG-2013

Ottawa 06-AUG-2013 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the parties are to provide their availability for a CMC/trial management conference with Manson J. by August 8th. By August 15th they are to provide a draft amended timetable held in chambers by way of Conference Call Duration per day: 06-AUG-2013 from 11:00 to 11:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: David Scrimger and Jenene Roberts 416-597-6262- representing Apotex Jordana Sanft 416-317-4613 representing GSK Jane Caskey 416-458-9840 representing GSK Daniel Daniele 416-216-2317 representing GSK Carol Hitchman Alisse Houweling 416-865-8259 representing PMS in T-2101-09 Christopher Tan and Warren Sprigings 416-777-2647 representing PMS in T-643-10 Minutes of Hearing entered in Vol. 884 page(s) 477 - 478 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 02-AUG-2013 re: Preparation of the file for the case conference on August 6, 2013

Letter from GlaxoSmithKline dated 02-AUG-2013 in response to the letter from Mr. Tan dated July 29, 2013 received on 02-AUG-2013

Letter from Pharmascience dated 01-AUG-2013 providing the Court with a status report received on 01-AUG-2013

Letter from Pharmascience dated 29-JUL-2013 requesting that the issues in theletter be discussed at the case conference on August 6, 2013 received on 29-JUL-2013

Letter from Defendant dated 31-JUL-2013 providing the court with dates of availability to continue the mediation received on 31-JUL-2013

Oral directions received from the Court: Chief Justice Crampton dated 29-JUL-2013 directing that Madam Prothonotary Aronovitch will be on sabbatical from August 16, 2013 to December 30, 2013. In her absence, Mr. Justice Manson is hereby assigned as case management judge in respect to the above noted file. Parties are to continue to send draft orders, directions and correspondence to cmt_ottawa@cas-satj.gc.ca. placed on file on 29-JUL-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-JUL-2013 directing that There will be a case management conference, by teleconference on August 6, 2013, for one hour, commencing at 11:00 placed on file on 29-JUL-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 29-JUL-2013 re: by email informing the Court of the dates of availability of the parties to attend a CMC

Memorandum to file from Annette Houle, Ottawa dated 29-JUL-2013 parties provided their availability for a CMC. The parties are available after 2:00 on July 30, 2013 and all day on August 6, 2013 placed on file.

Copy of Oral Direction dated 22-JUL-2013 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-14-09

Communication to the Court from the Registry dated 12-JUL-2013 re: the Requisition for PTC and Apotex's letter dated 28-Jun-2013 providing a status re: mediation

Letter from Apotex dated 28-JUN-2013 advising of status of mediation process received on 28-JUN-2013

Copy of Letter dated 2-JUL-2013 on behalf of Plaintiff placed on file on 02-JUL-2013 Original filed on Court File No. T-14-09

Copy of Request for PTC on behalf of Plaintiff placed on file on 28-JUN-2013 Original filed on Court File No. T-14-09

Toronto 27-JUN-2013 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: The Mediation scheduled for 5-8 Nov, 2013 is re-scheduled to Nov. 18-21 at 10:00am. a case management conference will be held Nov 4 at 10:00am. Parties are to send mediation material(minus exhibits) to the court. held in chambers Duration per day: 27-JUN-2013 from 10:00 to 10:35 Courtroom : Judge's Chambers - Toronto Court Registrar: Jacqueline Smith Total Duration: 35min Appearances: Mr. Warren Sprigings 416-777-2273 representing Plaintiff Mr. Christopher Tan 416-777-2273 representing Plaintiff Ms. Jane Caskey 416-216-4000 representing Defendant Ms. Jordana Sanft 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 883 page(s) 199 - 200 Abstract of Hearing placed on file

Status report on behalf of Apotex (sent to the CMJ on 10-Jun-2013) received on 07-JUN-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 3-Jun-2013 placed on file on 05-JUN-2013

Copy of Letter from Norton Rose Fulbright Canada LLP / s.e.n.c.r.l., s.r.l. dated 13-MAY-2013. re: Change of company name. Copy placed on 62 files. placed on file on 29-MAY-2013 Original placed on Court File No. T-2022-89

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-JUN-2013 directing that parties are to advise the case management judge of the dates fixed for further settlement conferences within a week of the dates having been fixed placed on file on 03-JUN-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 30-MAY-2013 pursuant to paragraph 2 of the Order of 24-Apr-2013 (sent to CMJ on 31-May- 2013) received on 31-MAY-2013

Copy of Order dated 13-MAY-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-2101-09

Toronto 13-MAY-2013 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Mediation scheduled for 28-31 May, has been adjourned. A Case Management Conference will be held 27-jun-2013 at 10am, Mediation scheduled 5-8-nov-2013, Expert reports(text only) to be submitted for the mediation process. held in chambers Duration per day: 13-MAY-2013 from 10:30 to 11:20 Courtroom : Judge's Chambers - Toronto Court Registrar: Jacqueline Smith Total Duration: 50min Appearances: Mr Warren Sprigings 416-777-2273 representing Plaintiff Ms Jane Caskey 416-216-4000 representing Defendant Ms Jordana Sanft 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 880 page(s) 367 - 368 Abstract of Hearing placed on file

Draft Order concerning the Trial Management Conference held on May 9, 2013. received on 10-MAY-2013

Ottawa 09-MAY-2013 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: Extension of 1 week granted. Mr. Topolski to send a draft order to the Court held by way of Conference Call Duration per day: 09-MAY-2013 from 01:30 to 01:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Benoit Labelle Total Duration: 15min Appearances: Mr. Jerry Topolski (416) 597-5907 representing Plaintiff Ms. Jordana Sanft, Ms.Jane Caskey, Mr. Patrick Kearns (416) 216-4798 representing GlaxosmithKline Mr. Christopher Tan and Mr. Warren Sprigings (416) 777-0888 representing Pharmascience in T-643-10 Mr. Alisse Houwelling (416) 865-6600 representing Pharmascience in T-2101-09 Comments: Matter heard with T-14-09 and T-2101-09. Minutes of hearing taken on T-14-09 Minutes of Hearing entered in Vol. 880 page(s) 252 - 253 Abstract of Hearing placed on file

Letter from Apotex dated 08-MAY-2013 requesting an urgent trial management conference with Snider J. to discuss an extension of time to deliver expert reports received on 08-MAY-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-May-2013 placed on file on 07-MAY-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-MAY-2013 directing that in light of correspondence from GSK and Apotex dated May 6, 2013, respectively, parties are advised to request a teleconference with Snider J. to deal with the request for an extension. The case management conference fixed for 3:00 p.m. today is accordingly adjourned sine die placed on file on 07-MAY-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 06-MAY-2013 in reply to GSK's letter dated 6-May-2013 (given to the CMJ on May 7, 2013 at 9:30 a.m.) received on 07-MAY-2013

Letter from GSK dated 06-MAY-2013 in response to Apotex's letter dated 2-May-2013 (given to the CMJ on May 7, at 9:30 a.m.) received on 06-MAY-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-MAY-2013 directing that a case management teleconference will take place on May 7, 2013 at 3:00 a.m. placed on file on 03-MAY-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 02-MAY-2013 requesting a CMC to discuss issues that arose which are going to make it difficult for them to complete their expert reports received on 02-MAY-2013

Copy of Order dated 24-APR-2013 rendered by Roza Aronovitch, Prothonotary concerning timetable placed on file. Original filed on Court File No. T-2101-09

Draft Order concerning direction dated 4-Mar-2013 and letter dated 17-Apr-2013 received on 19-APR-2013

Communication to the Court from the Registry dated 18-APR-2013 re: ID 435

Letter from defendants in T-2101-09 dated 17-APR-2013 providing a consolidated timetable per direction of March 4, 2013 received on 17-APR-2013

Acknowledgment of Receipt received from all parties with respect to Doc. #83 (Order of Aronovitch P., dated March 21, 2013) placed on file on 21-MAR-2013

Order dated 21-MAR-2013 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 74 Result: THIS COURT ORDERS that: 1. PMS shall answer the following questions: a. Item Nos. 6-8 and 17; and b. Item No. 13: with no opportunity for follow-up. 2. Answers to the questions ordered or agreed to be answered shall be provided by March 31, 2013. 3. There shall be no costs awarded for this motion. Filed on 21-MAR-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1187 page(s) 321 - 323 Interlocutory Decision

Acknowledgment of Receipt received from all parties with respect to ID# 431 (Order of Aronovitch P., dated March 21, 2012) placed on file on 21-MAR-2013

Copy of Order dated 21-MAR-2013 rendered by Roza Aronovitch, Prothonotary concerning Motion Doc. #79 placed on file. Original filed on Court File No. T-2101-09

Acknowledgment of Receipt received from all parties by email with respect to the Direction of the Court (Snider J.) dated March 21, 2013 placed on file on 21-MAR-2013

Oral directions received from the Court: The Honourable Madam Justice Snider dated 21-MAR-2013 directing that "The Court is amenable to receiving the Trial Record on November 22, 2013." placed on file on 21-MAR-2013

Draft Order relating to Motion Doc. No. 74 approved as to form and content by all parties (sent to CMJ on 20-Mar-2013) received on 19-MAR-2013

Draft Order relating to Motion Doc. No. 79 approved as to form and content by all parties (sent to CMJ on 20-Mar-2013) received on 19-MAR-2013

Letter from Defendants in Court File T-2101-09 dated 14-MAR-2013 Advising that parties consent to the submission of trial records on November 22, 2013, and asking whether this is acceptable to the Court. received on 14-MAR-2013

Ottawa 06-MAR-2013 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 74 on behalf of Plaintiff Result of Hearing: Matter granted held in Court by way of video conference Senior Usher: D. Lehman Duration per day: 06-MAR-2013 from 11:15 to 12:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Christopher Tan 416-777-2647 representing Plaintiff Daniel Daniele 416-216-4000 representing Defendant Comments: Mr. Daniele will provide a draft order Minutes of Hearing entered in Vol. 876 page(s) 363 - 366 Abstract of Hearing placed on file

Toronto 04-MAR-2013 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: the trial files T-643-10 & T-2101-09 will take place Jan 7/14 in Toronto. The Pharmascience trials shall be consolodated with T-14-09. The consolodated trial will continue for a duration of 40 days. Order to follow held in Court Duration per day: 04-MAR-2013 from 03:30 to 04:35 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Michael Pace Total Duration: 1h 5min Appearances: Patrick Kierans 416-216-3904 representing GSK Jane Caskie 416-216-1925 representing GSK Jordana Sanft 416-216-1925 representing GSK Daniel Daniele 416-216-1925 representing GSK Carole Hitchman 416-865-8259 representing Pharmascience Alissa Houweling 416-865-8259 representing Pharmascience Warren Sprigings 416-777-0888 representing Pharmascience Christopher Tan 416-777-0888 representing Pharmascience David Scrimger 416-597-6262 representing Apotex Ken Crowfoot 416-979-2211 representing Apotex Comments: Mr. Daniel Daniele took minutes for counsel. Minutes for the Court on files T-2101-09, T-643-10 & T-14-09 can be found with T-2101-09 Mr. Charles Kinzig (VP for GSK) sat in this conference. Minutes of Hearing entered in Vol. 876 page(s) 333 - 334 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Written Directions of the Court dated 4-MAR-2013 placed on file on 04-MAR-2013

Order dated 05-MAR-2013 rendered by The Honourable Madam Justice Snider Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: 1) The joint trial of T-643-10 & T-2101-09 shall take place 07-JAN-2014 in Toronto; 2) The Pharmascience trials shall be consolidated with the trial of T-14-09; 3) The consolidated trial will continue for a duration of: (a) no longer than 40 sitting days for the evidentiarty portion of the trial; (b) no longer than 5 sitting days for final argument; 4) A copy of this Order shall be placed on T-14-09. Filed on 05-MAR-2013 certified copies sent to parties entered in J. & O. Book, volume 1186 page(s) 40 - 42 Interlocutory Decision

Communication to the Court from the Registry dated 20-FEB-2013 re: consolidated timetable of steps further to the Direction of the Court 4-FEB- 2013

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 04-MAR-2013 directing that "The parties are to resubmit a consolidated timetable after March 4, 2013 including: 1. The fixing of trial date for the three actions and the number of days for trial 2. A timetable for status reports 3. Dates for the filing of trial records after confirmation by Justice Snider 4. A fixed date by which parties will request a trial management conference 5. A mechanism for reporting on the date of any further settlement conferences and reporting to the Court thereafter." placed on file on 04-MAR-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Madam Justice Snider dated 28-FEB-2013 directing that the TMC originally scheduled for 3:00 pm March 4/13 is now scheduled for 3:30 pm Monday Mar. 4/13. placed on file on 28-FEB-2013

Draft Order concerning letter dated 15-Feb-2013 (sent up to the CMJ on 20-Feb-2013) received on 19-FEB-2013

Letter from counsel for PMS in T-2101-09 dated 15-FEB-2013 providing a consolidated timetable on consent as required by the direction of the Court dated 4-Feb-2013 received on 15-FEB-2013

Oral directions received from the Court: The Honourable Madam Justice Snider dated 13-FEB-2013 directing that "A Trial Management Conference will take place March 4, 2013 in Toronto in person at 3 pm, for a duration of no longer than 2 hours." placed on file on 13-FEB-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 11-FEB-2013 requesting a trial management conference further to the direction of Madam Aronovitch dated 4-Feb-2013 Letter was scanned to Trial Judge's attention. received on 11-FEB-2013

Letter from GSK dated 08-FEB-2013 providing a status report as required by par. 8(a) of the 25-May-2012 Order (sent to the CMJ on 11-Feb-2013) received on 08-FEB-2013

Acknowledgment of Receipt received from All parties with respect to the Oral Directions (2) from Aronovitch, P. dated February 4, 2013. placed on file on 04-FEB-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 04-FEB-2013 directing that "Re: Correspondence on behalf of GSK dated January 30, 2013, requesting and extension of time until June 28, 2013 to serve and file its request for PTC Granted. In light of the trial of the three actions in January 2014, by February 15, 2013, parties are to file one consolidated revised timetable of further steps in the three actions." placed on file on 04-FEB-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 04-FEB-2013 directing that "Re: Correspondence on behalf of GSK dated January 28, 2013 and on behalf of Apotex and Pharmascience dated February 1, 2013. By February 11, 2013, parties are to jointly request a trial management conference with Justice Snider to fix the length of the trial of the three actions starting on January 13, 2014." placed on file on 04-FEB-2013 Confirmed in writing to the party(ies)

Memorandum to file from Julie Dulac dated 04-FEB-2013 the parties' correspondence dated 28-Jan-2013 and 1-Feb-2013 in response to the Court's direction dated 25-Jan-2013 was placed before the CMJ today placed on file.

Letter from PMS and on behalf of PMS in T-2101-09 and Apotex dated 01-FEB-2013 providing submissions further to the Court's direction of 25-Jan-2013 received on 01-FEB-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 30-Jan-2013 placed on file on 31-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-JAN-2013 directing that further to Mr. Tan's letter of 28-Jan-2013 requesting an extension of time to comply with the direction of the Court datd 25-Jan-2013 the request is granted placed on file on 30-JAN-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 30-JAN-2013 requesting an extension of time to serve and file a request for PTC received on 30-JAN-2013

Communication to the Court from the Registry dated 29-JAN-2013 re: the parties' correspondence dated 28-Jan-2013

Letter from counsel for PMS in T-643-10 dated 28-JAN-2013 on their behalf and on behalf of counsel for PMS in T-2101-09 and counsel for Apotex in T-14-09 received on 28-JAN-2013

Letter from GSK dated 28-JAN-2013 in response to the Court's direction dated 25-Jan-2013 received on 28-JAN-2013

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated January 24, 2013. placed on file on 25-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 24-JAN-2013 directing that "Re: Trial Dates: T-2101-09, T-643-10, T-14-09 It is my understanding that in the course of a mediation of the issues in the above-noted actions, held in December 2012, the parties reached an agreement to vacate the dates for the trial of the actions in T-2101-09 and T-643-10, set down for hearing for 40 days commencing on September 9, 2013, before Justice Snider, and instead, have agreed to have the trial of the three actions proceed together on the basis of consolidated expert evidence, before Justice Snider, on January 13, 2014, for 25 days, being the dates fixed for the trial of T-14-09 alone. Before the September dates can be vacated, the parties will have to confirm the above-noted agreement, and that the 25 days set aside in January will suffice for the trial of the three actions. Parties are reminded that the 40 days in September had included consideration of time needed for simultaneous translation. Parties are to confirm, or comment, including as to the sufficiency of the 25 days, by no later than January 28, 2013." placed on file on 24-JAN-2013 Confirmed in writing to the party(ies)

Copy of Written Direction dated 23-JAN-2013 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

Letter from PMS in T-2101-09 dated 16-JAN-2013 attaching a draft direction further to the CMC held on 11-Jan-2013. Sent to the CMJ on 17-Jan-2013 received on 16-JAN-2013

Ottawa 11-JAN-2013 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the rescheduling of the refusals motions in this file and in T-2101-09 Result of Hearing: See abstract in T-2101-09 held by way of Conference Call in chambers Duration per day: 11-JAN-2013 from 10:25 to 10:55 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Christopher Tan 416-777-2647 representing Plaintiff Jordana Sanft and Keith Aguilera 416-216-1925 representing GSK Minutes of Hearing entered in Vol. 873 page(s) 456 - 457 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 8-Jan-2013 placed on file on 08-JAN-2013

Letter from GSK dated 09-JAN-2013 requesting that the refusals motions which were scheduled to take place on January 9 to 11, 2013 and adjourned, be rescheduled during the week of January 14, 2012 received on 09-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 08-JAN-2013 directing that a case management teleconference will take place on Friday January 11, 2013 at 10:00 a.m. to discuss the rescheduling of the refusals motions originally scheduled to take place on January 9, 10 and 11, 2013 and now adjourned placed on file on 08-JAN-2013 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 20-Dec-2012 placed on file on 21-DEC-2012

Copy of Order dated 21-DEC-2012 rendered by Roza Aronovitch, Prothonotary concerning motion doc. 81 placed on file. Original filed on Court File No. T-2101-09

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-DEC-2012 directing that the plaintiffs in T-2101-09 and T-643-10 are granted an extension of time until January 31, 2013 to serve and file a request for pre-trial conference placed on file on 20-DEC-2012 Confirmed in writing to the party(ies)

Ottawa 20-DEC-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: The hearing scheduled on 21-Dec-2012 is adjourned to 9-Jan-2013 at 9:30 for 4hours held in chambers by way of Conference Call Duration per day: 20-DEC-2012 from 02:45 to 02:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 5min Appearances: Keith Aguilera 416-216-1925 representing GSK Christopher Tan 416-777-2647 representing PMS Minutes of Hearing entered in Vol. 873 page(s) 203 - 204 Abstract of Hearing placed on file

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-DEC-2012 directing that The motion set down for hearing in Ottawa on December 21, 2012 is hereby adjourned to be heard in Ottawa on January 9, 2013, commencing at 9:30 a.m. for 4 hours. PMS and Apotex's motion to compel GSK (Dr. Krenitsky) is scheduled to be heard in Ottawa for 1.5 days commencing on January 10, 2013 at 9:30 a.m. placed on file on 20-DEC-2012 Confirmed in writing to the party(ies)

Draft Order concerning Motion Doc. No. 81 consented to by all parties received on 20-DEC-2012

Letter from GSK dated 17-DEC-2012 advising of remaining questions to be adjudicated on 21-Dec-2012 (communicated to the CMJ on 17-Dec-2012) received on 17-DEC-2012

Communication to the Court from the Registry dated 17-DEC-2012 re: PMS's letters dated 7-Dec-2012 re: status report and request for an extension of time to provide draft order re: refusals and GSK's letter dated 13-Dec-2012

Letter from GSK dated 13-DEC-2012 requesting an extension of time until 31-Jan-2013 to serve and file a request for pre-trial conference received on 14-DEC-2012

Toronto 10-DEC-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Mediation Result of Hearing: Matter adjourned sine die held in Court Senior Usher: Anne Street 10-DEC-2012 Anne Street 11-DEC-2012 Anne Street 12-DEC-2012 Duration per day: 10-DEC-2012 from 10:00 to 04:30 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith 11-DEC-2012 from 09:30 to 04:50 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith 12-DEC-2012 from 10:00 to 12:50 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith Total Duration: 2.5d Appearances: Mr Warren Sprigings 416-777-0888 representing Plaintiff Mr. Christopher Tan 416-777-0888 representing Plaintiff Ms. Jane Caskey 416-216-3930 representing Defendant Ms. Jordana Sanft 416-216-3930 representing Defendant Minutes of Hearing entered in Vol. 872 page(s) 311 - 312 Abstract of Hearing placed on file

Letter from Plaintiff dated 07-DEC-2012 on behalf of defendants in T-2101-09 and GSK request extension of deadline to file orders from motions to compel until December 19,2012. received on 07-DEC-2012

Letter from Plaintiff dated 07-DEC-2012 Update report on proceedings provided in paragraph 8(d) Order dated May 25,2012. Motion to continue December 21,2012 and January 10-11/13. Answers to undertakings by January 31,2013;Mediation Briefs exchanged November 13,2012 and responding mediation brief by December 5,2012; Mediation before Prothonotary Aalto December 10-13,2012. For attention Prothonotary Aronovitch. received on 07-DEC-2012

Ottawa 28-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 81 on behalf of PMS Result of Hearing: Matter partially granted held in Court Senior Usher: S. Young Duration per day: 28-NOV-2012 from 10:00 to 11:45 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 29-NOV-2012 from 09:30 to 05:05 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 30-NOV-2012 from 09:30 to 03:20 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 2d Appearances: Christopher Tan and Patrick Hui 416-777-2647 representing PMS Keith Aguilera and William Pellerin 416-216-1925 representing GSK Draft Decision to be submitted by PMS Minutes of Hearing entered in Vol. 872 page(s) 50 - 51 Abstract of Hearing placed on file

Notice of Motion on behalf of PMS returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling GSK (Cindy Roll and Norman Vojir) (motion record only filed in T-14-09 Doc. 76 along with joint brief of relevant documents Doc. 77)(sealed per protective order dated 29-Jun-2011) filed on 19-NOV-2012

Memorandum to file from Julie Dulac dated 28-NOV-2012 the document required by the direction of the Court dated 27-Nov-2012 was placed in T-14-09 only placed on file.

Acknowledgment of Receipt received from all parties with respect to the Oral Direction of Aronovitch P., dated November 27, 2012 placed on file on 27-NOV-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-NOV-2012 directing that "Plaintiffs are to make preliminary submissions in writing, in point form by way of an overview, regarding the identity and relationship of the corporate plaintiffs, their respective roles in the manufacture, promotion and sale of valacyclovir, in Canada. Any agreements of the parties that relate to the above are to be noted by reference to the production found in the joint book of documents, which is to include a brief description of the nature of the document." placed on file on 27-NOV-2012 Confirmed in writing to the party(ies)

Ottawa 22-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the Court decided on the order in which the motions are going to be dealt with on 28-Nov-2012 held in chambers by way of Conference Call Duration per day: 22-NOV-2012 from 10:00 to 10:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Christopher Tan 416-777-2647 representing PMS Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Minutes of Hearing entered in Vol. 871 page(s) 280 - 281 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Rosamaria Longo confirming service of doc. 79 upon Defendant by e-mail on 06-NOV-2012 filed on 19-NOV-2012

Notice of Motion on behalf of Plaintiff returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling answers of GSK paries' representative Dr. Krenitsky (Sealed per protective order dated 29-Jun-2011)(complete motion record filed in T-14-09 only under doc. no. 73) filed on 19-NOV-2012

Letter from Defendants in T-2101-09 dated 22-NOV-2012 advising that 65 questions need adjudication in motion to compel GSK re: Dr. Krenitsky received on 22-NOV-2012

Covering letter from PMS dated 19-NOV-2012 concerning Doc. Nos. 76 77 placed on file on 19-NOV-2012

Solicitor's certificate of service on behalf of Christopher Tan confirming service of docs 76 77 upon GSK by personal service on 19-NOV-2012 filed on 19-NOV-2012

Responding book of authorities of PMS re: GSk's motion to compel PMS consisting of 1 volume(s) on behalf of PMS (also filed re: motions 110,114,118 and 122 in T-2101-09) received on 19-NOV-2012

Aide-memoire re: motion doc. 74 (sealed)(only one copy for Judge) filed on 19-NOV-2012

Motion Record containing the following original document(s): 74 75 Number of copies received: 2 on behalf of Plaintiff (whole document sealed) filed on 19-NOV-2012

5 column chart re: motion doc. 74 filed on 19-NOV-2012

Notice of Motion contained within a Motion Record on behalf of GSK returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling Pharmascience Inc. (Debbie Ship) filed on 19-NOV-2012

Ottawa 08-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss issues raised in correspondence dated November 1, 2 and 6, 2012 Result of Hearing: See abtract in T-14-09 held in chambers by way of Conference Call Duration per day: 08-NOV-2012 from 03:00 to 03:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: Christopher Tan 416-777-2647 representing PMS Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Minutes of Hearing entered in Vol. 870 page(s) 378 - 379 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction dated 7-Nov-2012 placed on file on 07-NOV-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 06-NOV-2012 directing that a CMC by TC will proceed on 8-Nov-2012 at 3:00 p.m. placed on file on 07-NOV-2012 Confirmed in writing to the party(ies)

Letter from GSK dated 06-NOV-2012 in response to Apotex's November 2, 2012 letter (given to the CMJ on 7-Nov- 2012) received on 06-NOV-2012

Communication to the Court from the Registry dated 02-NOV-2012 re: (verbal communication) GSK's letter dated 1-Nov-2012. The CMJ asked that I advise GSK that before calling a CMC she will await a response from GSK to Apotex's letter dated 2-Nov-2012 in T-14-09

Letter from GSK dated 01-NOV-2012 advising that they were served with a Notice of Inter Partes Testing and requesting a CMC so that issues can be resolved received on 01-NOV-2012

MEMORANDUM to CMJ- Aronovitch, P., from S. Mbuyi, Actions Section enclosing certified copy of Reasons for Order and Order doc.73 of O'Keefe, J. received on 30-OCT-2012

Acknowledgment of Receipt received from parties with respect to doc.#73 placed on file on 29-OCT-2012

Reasons for Order and Order dated 29-OCT-2012 rendered by The Honourable Mr. Justice O'Keefe Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 64 Result: "THIS COURTS ORDERS that: 1.The Prothonotary's order is set aside with respect to the following questions in Schedule "C" to the order: Category 1: Items 2, 11, 29 Category 4: Items 68-69, 73, 80-82, 86, 87, 98-99 Category 8: Items 162, 163, 165 2. Pharmascience Inc., Laboratoire Riva Inc., Pro Doc Limitée, Dominion Pharmacal, Zymcan Pharmaceuticals Inc., Pharmel Inc. and Apotex Inc. shall have their costs of the motion." Filed on 29-OCT-2012 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1172 page(s) 325 - 327

Acknowledgment of Receipt received from all parties with respect to the written direction of Aronovitch, P. dated October 19, 2012 placed on file on 19-OCT-2012

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 19-OCT-2012 directing that 1. Second-round motions to compel a) The second-round motions to compel, previously ordered to take place for five days in Toronto commencing on November 26, 2012, are hereby adjourned to commence on November 28, 2012, at 10:00 a.m. in Ottawa. b) The parties' motions in respect of financial issues shall be heard on November 28 and 29, 2012, in Ottawa. c) Apotex and PMS et al.'s motion in respect of scientific issues shall be heard on November 30, 2012, (and if necessary, December 21, 2012) in Ottawa. 2. Motion records for second-round motions to compel The dates for the parties to exchange their moving and responding motion records, previously ordered to occur on October 26 and November 16, 2012, respectively, are hereby amended as follows: a) Moving parties' motion records shall be served by November 2, 2012. b) Responding parties' motion records shall be served and filed, in Ottawa, to the attention of Julie Dulac, by November 19, 2012. placed on file on 19-OCT-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 16-OCT-2012 re: the parties' draft direction rec'd 12-Oct-2012

Draft direction concerning CMC held 9-Oct-2012 consented to by all parties received on 12-OCT-2012

Ottawa 09-OCT-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Ms. Sanft will prepare a draft order and submit it by Friday October 12, 2012 held in chambers by way of Conference Call Duration per day: 09-OCT-2012 from 03:00 to 03:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 25min Appearances: Christopher Tan 416-777-2647 representing Pharmascience Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Comments: see abstract in T-14-09 Minutes of Hearing entered in Vol. 869 page(s) 13 - 14 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 2-Oct-2012 placed on file on 02-OCT-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 02-OCT-2012 directing that a case management teleconference will take place on October 9, 2012 at 3:00 p.m. placed on file on 02-OCT-2012 Confirmed in writing to the party(ies)

Copy of Notice of Discontinuance on behalf of Appellant placed on file on 20-SEP-2012 Original filed on Court File No. A-294-12

Toronto 12-SEP-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: minutes can be found on T-14-09 held in ADR Room Senior Usher: Ken Massey Duration per day: 12-SEP-2012 from 01:00 to 02:00 Courtroom : Discovery Room No. 4-45 - Toronto Court Registrar: Shaun Nelson Total Duration: 1h Appearances: Mr. Sprigings and Mr. Tan 416-777-2273 representing Plaintiff Ms. Caskey, Ms. Sanft 416-216-1899 representing Defendant Minutes of Hearing entered in Vol. 867 page(s) 428 - 429 Abstract of Hearing placed on file

Letter from GlaxoSmithKline Inc. dated 11-SEP-2012 providing the court with an agenda for the CMC scheduled for 12-SEP-2012 received on 11-SEP-2012

Letter from Pharmascience Inc. dated 11-SEP-2012 providing the court with an agenda for the CMC scheduled 12-SEP-2012 received on 11-SEP-2012

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 23-AUG-2012 directing that the CMC shall reconvene on 12-SEP-2012 at 1:00 and will be in person placed on file on 23-AUG-2012

Toronto 23-AUG-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: please see minutes on T-14-09 held by way of Conference Call in chambers Duration per day: 23-AUG-2012 from 01:10 to 01:40 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 30min Appearances: Mr. Sprigings, Mr. Tan 416-777-2273 representing Plaintiff Ms. Sanft, Ms. Casky, Mr. Aguilera 416-216-4798 representing Defendant Minutes of Hearing entered in Vol. 866 page(s) 497 - 498 Abstract of Hearing placed on file

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 15-AUG-2012 directing that a CMC has been scheduled for 23-AUG-2012 starting at 1:00PM placed on file on 15-AUG-2012

Letter from Defendant dated 10-AUG-2012 requesting a CMC with Prothonotary Aalto to discuss dates for a DRC received on 10-AUG-2012

Letter from Apotex Inc. dated 13-AUG-2012 providing update on scheduling orders of the court. received on 13-AUG-2012

Letter from GSK dated 01-AUG-2012 advising of dates for meetings re: unanswered questions received on 01-AUG-2012

Memorandum to file from C. Doré, Ottawa dated 09-JUL-2012 A copy of the Notice of Appeal was sent to the Case Management Judge. (Aronovitch,P.) placed on file.

Copy of Notice of Appeal (Appeal Court File No. A-294-12 ) appealing the Order of The Honourable Mr. Justice O'Keefe dated June 11, 2012 filed in the Court of Appeal on 21-JUN-2012 on behalf of Appellant placed on file on 06-JUL-2012

Communication to the Court from the Registry dated 26-JUN-2012 re: Letters from parties dated June 21 and June 22, 2012.

Letter from Plaintiff (Carol Hitchman) dated 22-JUN-2012 responding to GSK letter sent to Court June 21, 2012. We concur with the submissions made by Apotex that it is unnecessary to redact the subject matter of items 2, 11 and 29 on page 9 of the Draft Confidential Reasons of Justice O'Keefe rendered on June 11, 2012. received on 22-JUN-2012

Letter from Defendant (GSK Inc.) dated 21-JUN-2012 Pursuant to paragraph 31 of Mr. Justice O'Keefe's decision dated June 11, 2012, the parties were given 10 days request deletion of any material from the decision that they believe is confidential. GSK submits that the questions excerpted at paragraph 15 of the decision contain information that is confidential scientific work. Accordinly, GSK respectfully requests that the text of Item #'s 2, 11, and 29 be deleted or redatcted in the public version of the reasons. received on 21-JUN-2012

Copy of Confidential Draft Reasons for Order and Order dated 11-JUN-2012 rendered by The Honourable Mr. Justice O'Keefe placed on file. Original filed on Court File No. T-2101-09

Letter from GSK dated 08-JUN-2012 providing status report received on 08-JUN-2012

Communication to the Court from the Registry dated 13-JUN-2012 re: GSK's status report

Letter from Defendant dated 30-MAY-2012 requestion a case management conference with Prothonotary Aalto to discuss the conducting of a mediation in this matter. received on 30-MAY-2012

Copy of Order dated 25-MAY-2012 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-14-09

Draft Order concerning CMC held May-15-2012 (sent electronically to the CMJ on 15-May-2012) consented to by all parties received on 18-MAY-2012

Ottawa 15-MAY-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: See abstract in T-14-09 held in chambers by way of Conference Call Duration per day: 15-MAY-2012 from 03:00 to 03:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 25min Appearances: Christopher Tan (and Véronique Duval-in house for Pro-Doc 450-646-9611) 416-777-2647 representing PMS Jordana Sanft, Jane Casky and Keith Aguilera 416-216-4798 representing GSK Comments: See comments in T-14-09 Minutes of Hearing entered in Vol. 862 page(s) 273 - 274 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 18-APR-2012 re: the draft order rec's 17-Apr-2012 re: CMC held 10-Apr-2012

Draft Order concerning CMC held 10-Apr-2012 consented to by all parties received on 17-APR-2012

Ottawa 10-APR-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss mediation and timetable Result of Hearing: the CMJ will leave it up to the parties to communicate with Aalto P. and request a teleconference to discuss scheduling the mediation and the subject of the mediation. The CMJ asked GSK to prepare a consolidated timetable which includes all remaining timelines in all three files held in chambers by way of Conference Call Duration per day: 10-APR-2012 from 10:00 to 11:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Christopher Tan (and Caroline McNicholl in house counsel) 416-777-2647 representing PMS Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Minutes of Hearing entered in Vol. 860 page(s) 248 - 249 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 05-APR-2012 re: in preparation for the CMC scheduled 10-Apr-2012

Letter from counsel for PMS in T-2101-09 on behalf of all parties dated 05-APR-2012 in preparation for the CMC scheduled April 10, 2012 and addressing the Court's concerns as stated in the direction of 28-Mar-2012 received on 05-APR-2012

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Mar-2012 placed on file on 28-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-MAR-2012 directing that a case management teleconference will take place on April 10, 2012 at 10:00 placed on file on 27-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-MAR-2012 directing that the case management teleconference scheduled to take place today at 4:00 p.m. is adjourned to a date to be determined. The parties are to provide their availability by the end of the day tomorrow for a case management teleconference in the two weeks following placed on file on 19-MAR-2012 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 16-MAR-2012 requesting to reschedule the CMC scheduled for March 19th @4:00pm received on 16-MAR-2012

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated March 5, 2012. placed on file on 06-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 05-MAR-2012 directing that a case management teleconference will take place on March 19, 2012 at 4:00 pm to discuss the mediation placed on file on 05-MAR-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 20-FEB-2012 re: parties' letters re: status of discussions re: mediation

Letter from counsel for PMS in T-2101-09 on behalf of counsel in this file dated 17-FEB-2012 advising of status of discussions re: mediation received on 17-FEB-2012

Letter from GSK dated 17-FEB-2012 providing a status on the issue of a mediation and advising that the parties have not been able to come to an agreement of the scope of the mediation received on 17-FEB-2012

Acknowledgment of Receipt received from all parties (by FAX) with respect to the Amended Order of the Court dated 2-FEB-2012 placed on file on 02-FEB-2012

Amended Order rendered on 02-FEB-2012 by Roza Aronovitch, Prothonotary filed on 02-FEB-2012 Matter considered without personal appearance amending the Order of the Court dated 31-JAN-2012 entered in J. & O. Book, volume 1148 page(s) 37 - 39 Interlocutory Decision copies sent to parties

Acknowledgment of Receipt received from all parties (by FAX) with respect to the Order of the Court dated 31-JAN-2012 placed on file on 31-JAN-2012

Order dated 31-JAN-2012 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: Order to go as set out in Draft Order "1. The parties shall jointly report to the Court no later than February 17, 2012 regarding any agreement between the parties relating to the mediator and venue of the mediation in these proceedings. T-2101-09 / T-643-10 2. Dates for exchange of experts reports in-chief are to be determined pending the finalization of the timetable in T-14-09 as per paragraph 16 below. 3. The updated affidavit of documents of Dominion Pharmacal in T-2101-09 shall be delivered by February 10, 2012. 4. Discovery of Dominion Pharmacal in T-2101-09 shall be held on April 25, 2012 (and April 26, 2012, if necessary). 5. The expert reports in-chief shall include the following: (i) GSK expert reports relating to infringement and infringement damages in Court File No. T-2101-09. (ii) Pharmascience Inc. et al expert reports relating to validity in Court File No. 2101-09. (iii) Pharmascience Inc. expert reports relating to section 8 damages in Court File No. T-643-10. 6. Rebuttal expert reports to be delivered by July 15, 2013. 7. Initial requests to admit facts and documents served by July 15, 2013. 8. Service of proposed discovery read-ins shall be made by July 31, 2013. 9. Responses to any requests to admit facts and documents served 6-AUG-2013. 10. Reply expert reports delivered by August 12, 2013. 11. Service of proposed related parts to proposed discovery by 23-AUG-2013. 12. Motions to adjudicate questions from second round of discoveries are tentatively to be heard on October 29, 2012 to November 2, 2012. 13. A CMC to be held, if necessary, 15-MAY-2012 to review and fix dates for the tentatively reserved second refusals motion. 14. Plaintiffs in T-643-10 and T-2101-09 shall serve and file requests for PTC by 14-DEC-2012. The requirement under R. 258(4) is hereby waived. 15. A requisiton for trial management conference shall be made by the plaintiffs in T-643-10 and T-2101-09 at least 90 days before trial. T-14-09 16. Dates for the following items are the subject of continuing discussions between the parties to T-14-09 who must deliver to the Court a timetable on consent identifying dates for the items below by 8-FEB-2012 failing which a CMC shall be requested (...) 17. Expert reports in-chief shall include the following (...) 18. The motions to adjudicate questions (...) tentatively reserved to be heard 29-OCT-2012 to 2-NOV-2012. 19. A CMC shall be held, if necessary, 15-MAY-2012 to review and fix dates. 20. The plaintiff shall serve and file a request for PTC by 30-JUN-2013. The requirement under R. 258(4) (...) is hereby waived. 21. A requisition for trial management conference shal be made by plaintiff at least 90 days before trial. 22. A copy of this Order to be placed on T-14-09 and T-2101-09. Filed on 31-JAN-2012 copies sent to parties entered in J. & O. Book, volume 1147 page(s) 378 - 383 Interlocutory Decision

Communication to the Court from the Registry dated 27-JAN-2012 re: Draft Order received on 27-JAN-2012 following CMC 18-JAN-2012

Letter from Defendant dated 27-JAN-2012 attaching the Draft Order with the timelines established at the CMC 18-JAN-2012 received on 27-JAN-2012

Ottawa 18-JAN-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Counsel for PMS in T-2101-09 will submit a draft order by 27-Jan-2012 held in chambers by way of Conference Call Duration per day: 18-JAN-2012 from 03:05 to 04:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Christopher Tan 514-340-7845 (just for today) representing Plaintiff Jordana Sanft and Keith Aguilera 416-216-3904 representing Defendant Comments: see comments in T-2101-09 Minutes of Hearing entered in Vol. 855 page(s) 482 - 483 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 17-JAN-2012 re: in preparation for the CMC scheduled on 18-Jan-2012

Letter from Glaxo dated 16-JAN-2012 providing the Court with a proposed timetable on consent in preparation for the CMC scheduled on 18-Jan-2012 received on 16-JAN-2012

Communication to the Court from the Registry dated 28-DEC-2011 re: the plaintiff's letter dated 23-Dec-2011

Letter from Plaintiff dated 23-DEC-2011 providing status of the file per Order of 2-May-2011 received on 28-DEC-2011

Letter from defendants dated 21-DEC-2011 advising of schedule for second round of discoveries received on 21-DEC-2011

Copy of Order dated 20-DEC-2011 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

Communication to the Court from the Registry dated 19-DEC-2011 re: sending the draft proposed timetable to the CMJ

E-mail from Apotex attaching a draft proposed timetable on consent further to the CMC held on 14-Dec-2011 received on 19-DEC-2011

Ottawa 14-DEC-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the timetable going forward Result of Hearing: A partial timetable was established. A draft order re: that timetable will be provided by the end of the day 19-Dec-2011. A further CMC by TC was scheduled on 18-Jan-2011 to continue the discussion about timetable, discuss dates and venue for a judicially assisted mediation, scheduling of refusals motions arising out the 2nd round of discoveries and discuss the issues raised in the confidential correspondence submitted December 13 and 14, 2011 held by way of video conference Senior Usher: R. Héroux Duration per day: 14-DEC-2011 from 02:10 to 03:30 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Warren Sprigings and Christopher Tan 416-777-0888 representing Plaintiff Jordana Sanft and Keith Aguilera 416-216-4000 representing Defendant Comments: The Court reminded the parties that the timetable should include a date by which they are to requisition a pre-trial conference and pay the fee even though the trial has already been scheduled and that at the PTC, the trial duration will be fine tuned Minutes of Hearing entered in Vol. 854 page(s) 310 - 311 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 13-DEC-2011 re: in preparation for the CMC scheduled 14-Dec-2011

Toronto 12-DEC-2011 BEFORE The Honourable Mr. Justice O'Keefe Language: E Before the Court: Motion Doc. No. 64 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Joe Mischuk Duration per day: 12-DEC-2011 from 09:38 to 11:33 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil Total Duration: 1h 57min Appearances: Carol Hitchman/Arif Mahmood 416-865-8259 representing Plaintiff (Pharmascience) Lindsay Hill/David Scrimger 416-979-2211 representing Apotex (Plaintiff in T-14-09) Keith Aguilera/Jordana Sanft 416-216-3930 representing Defendant (Glaxosmithkline) Court Reporter: Calypso Schincariol (ASAP Reporting Services Inc.) 416-861-8720 12-DEC-2011 Transcript requested Minutes of Hearing entered in Vol. 854 page(s) 273 - 274 Abstract of Hearing placed on file

Joint Book of Authorities consisting of 4 volume(s) on behalf of all parties received on 09-DEC-2011

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of doc 69 upon all parties by process server on 09-DEC-2011 filed at hearing on 09-DEC-2011

Sealed envelope pursuant to the Court order dated January 12, 2011 and amended June 29, 2011 on behalf of Defendant purporting to contain Responding motion record of GSK Filed on 09-DEC-2011

Letter from Defendant dated 09-DEC-2011 Filing of documents in respect to motion for Dec 12, 2011;Joint authorities and Responding records (confidential) received on 09-DEC-2011

Letter from Jean-Charles René (Norton Rose Canada LLP) dated 05-DEC-2011 re: name and address change. received on 05-DEC-2011

Letter from Defendant dated 13-DEC-2011 providing their proposed timetable received on 13-DEC-2011

Letter from PMS (E-mail) dated 13-DEC-2011 attaching a proposed timetable for this file and T-2101-09 received on 13-DEC-2011

Sealed envelope pursuant to Protective Order dated 7-DEC-2009 on behalf of Plaintiff/Moving Party purporting to contain Joint Book of Relevant Documents (2 Volumes) Received on 07-DEC-2011

Sealed envelope pursuant to Protective Order dated 7-DEC-2009 on behalf of Plaintiff/Moving Party purporting to contain Motion Record containing the following original document (s): 67 Number of copies received: 3 Filed on 07-DEC-2011

Written Representations contained within a Motion Record on behalf of Plaintiff/Moving Party concerning Motion Doc. No. 64 filed on 07-DEC-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 01-DEC-2011 directing that The case management conference by teleconference scheduled for December 14, 2011 will no be heard by videoconference. If the parties indicate that the timetable will be on consent then the case management conference will be heard by teleconference. placed on file on 01-DEC-2011

Ottawa 01-DEC-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference To discuss extension of timelines for second round discovery Result of Hearing: The timelines are to be fixed and placed inthe new timetable which will be discussed at the case cofnerence on December 14, 2011 held by way of Conference Call Duration per day: 01-DEC-2011 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 35min Appearances: Mr. Tan 416-777-2647 representing Plaintiff Ms Sanft and Mr. Aigulera 416-216-4798 representing Defendant Comments: This matter was heard in conjunction with T-14-09 and T-2101-09. For full minutes see the Minutes in T-14-09 The Court Directed that the case management conference scheduled for December 14, 2011 would proceed at 2:00 by videoconference in lieu of a teleconference, but if the parties write to the Court that there is a timetable on consent the case management conference will be heard by teleconference. Mr. Tan is to provide fixed dates for himself and his clients for discovery to Ms Sanft by December 6, 2011. These timelines are to be placed in the timetable submitted on December 13, 2011. The Court indicated that the timelines in the timetable will be fixed for the date that the Trial is presently scheduled for. Parties are also to have a provision int he timetable for sample motions. Minutes of Hearing entered in Vol. 853 page(s) 393 - 394 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 30-NOV-2011 re: Preparation of the file for the CMC on December 1, 2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-NOV-2011 directing that There will be a case management conference, by teleconference on December 1, 2011, commencing at 10:00 for thirty minutes. placed on file on 30-NOV-2011 Confirmed in writing to the party(ies)

Letter from Pharmascience Inc dated 25-NOV-2011 providing dates of availability for a case conference received on 25-NOV-2011

Letter from Pharmascience dated 25-NOV-2011 providing dates of availability for a case conference received on 25-NOV-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated November 22, 2011. placed on file on 23-NOV-2011

Letter from GSK dated 24-NOV-2011 providing its availability for a CMC the week of 28-Nov-2011 received on 24-NOV-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 22-NOV-2011 directing that "By November 25, 2011 parties are to provide their availability to attend a case conference during the week of November 28, 2011 to discuss an extension of the timelines for the conclusion of the second round of discoveries. In the interim parties are to try to fix the dates for the completion of as much of the discoveries as possible by the end of February 2012." placed on file on 23-NOV-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 22-NOV-2011 re: sending the parties' correspondence re: moving up trial dates if dates become available to the Judicial Administrator and the CMJ as well as the correspondence re: issues with scheduling discoveries to the CMJ

Letter from PMS dated 18-NOV-2011 explaining why they are not available for 2nd round of discoveries in January and February 2012 and requesting that the time to compelte examinations for discovery be amended to April 30, 2012 received on 18-NOV-2011

Letter from GSK dated 18-NOV-2011 advising of dates for second round of discoveries and issues with scheduling discoveries with PMS and requesting a direction of the Court received on 18-NOV-2011

Letter from counsel for PMS in T-2101-09 on behalf of plaintiff in this file dated 15-NOV-2011 in response to the Court's direction dated 14-Nov-2011 and in response to GSK's letter dated 10-Nov-2011 received on 15-NOV-2011

Copy of Order **In regards to motion document #63)** dated 14-NOV-2011 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

Acknowledgment of Receipt received from All parties with respect to Doc. #66 (Order from Aronovitch, P. dated November 14, 2011). placed on file on 15-NOV-2011

Order dated 14-NOV-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 62 Result: Questions ordered answered 1. Pharmascience shall answer the first half of the question represented by Serial No. 1 (until "sales strategies"), by providing such information to May 2009, and further if appropriate. 2. Pharmascience shall answer the questions represented by Serial Nos. 2, 3 (in respect of the period of August 2007 to May 2008 for valacyclovir), 12, 14 (except for related documentation), 20, 21, 22, 23 (subsumed in 22), 38, 44, 45, 47, 49, 50, 51, 53, 54, 55, 56, 58, 60 (to the extent that the requested productions are non-expert evidence or non-privileged documents), and 82. 3. Pharmascience shall answer the question represented by Serial No. 4, as in the form of the question asked at page 8 of the discovery transcript. 4. Pharmascience shall answer the first part of the question represented by Serial No. 48, i.e. to the end of " ¿ when it entered the market". Pharmascience shall answer the remainder of the question represented by Serial No. 48 by providing its understanding, including any facts, and/or documents that are not privileged. Questions not ordered answered 5. Pharmascience need not answer the portion of the question represented by Serial No. 1 in respect of the request for internal sales staff correspondence, without prejudice to GSK's right to request such correspondence pending its review of the other documents ordered produced. 6. Pharmascience need not answer the question represented by Serial No. 24. Questions agreed upon between GSK and Pharmascience at the hearing of the motion Questions agreed to be answered by Pharmascience 7. Pharmascience agrees to provide an answer to the question represented by Serial No. 7, reworded as follows: "[a]dvise if there is any information or documentation that relates to PMS's ability or that of the supplier to manufacture the active during the time period August 2007 to May 2008." 8. Pharmascience agrees to provide an answer to the question represented by Serial No. 15 by providing sales information for tablets in terms of sales volumes and production volumes. 9. Pharmascience agrees to provide an answer to the question represented by Serial No. 16 by giving 5 examples. 10. Pharmascience agrees to provide an answer to the questions represented by Serial Nos. 13, 19, 36, and 67. Questions agreed to be withdrawn by GSK 11. GSK agrees to withdraw the questions represented by Serial Nos. 6 and 25. 12. GSK agrees to withdraw the question represented by Serial No. 9 on the basis that the Court ordered Pharmascience to provide an answer to the question represented by Serial No. 1, and without prejudice to GSK's right to request such documents pending its review of the documents ordered produced in respect of Serial No. 1. 13. GSK agrees to withdraw the question represented by Serial No. 61 on the basis that the Court ordered Pharmascience to provide an answer to the question represented by Serial No. 60. 14. GSK agrees to withdraw the question represented by Serial No. 68 on the basis that Pharmascience agrees to provide an answer to the question represented by Serial No. 67. 15. Pharmascience shall supply written answers to the questions it undertook to answer or that it has been ordered to answer on or before November 30, 2011. 16. There will be no costs of the motion. Filed on 14-NOV-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1141 page(s) 93 - 99 Interlocutory Decision

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated November 14, 2011. placed on file on 14-NOV-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 14-NOV-2011 directing that "Re: Correspondence of November 10, 2011 from Mr. Kierans Pharmascience will have until no later than November 18, 2011 to respond. The correspondence and response, if any, will thereafter be provided to the office of the Judicial Administrator." placed on file on 14-NOV-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 10-NOV-2011 re: GSK's letter dated 10-Nov-2011

Letter from GSK dated 10-NOV-2011 requesting that should Court dates become available prior to September 13, 2013, the Court seek to set down the hearing at such earlier date received on 10-NOV-2011

Copy of Order dated 04-NOV-2011 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

Communication to the Court from the Registry dated 01-NOV-2011 re: the status report submitted 28-Oct-2011 and the draft orders re: motions doc 62 and 63

Draft Order concerning Motion Doc. No. 63 received on 28-OCT-2011

Draft Order concerning Motion Doc. No. 62 received on 28-OCT-2011

Letter from PMS in T-2101-09 dated 28-OCT-2011 providing a status report per May 2, 2011 Order received on 28-OCT-2011

Ottawa 27-OCT-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss new dates for trial in 2013 Result of Hearing: The Court advised that the trial date has been changed to September 9, 2013 and that an Order scheduling the trial will be issued by the week of November 7, 2011 held in chambers by way of Conference Call Duration per day: 27-OCT-2011 from 02:00 to 02:10 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 10min Appearances: Ms. Jordana Sanft 416-216-4000 representing GSK Mr. Christopher Tan 416-777-0888 representing PMS Minutes of Hearing entered in Vol. 851 page(s) 452 - 453 Abstract of Hearing placed on file

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-OCT-2011 directing that granted the parties' request for an extension of the timeline set by paragraph 1k of the May 2, 2011 Order until November 30, 2011 placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from all parties with respect to the Court's directions dated 21-Oct-2011 and 26-Oct-2011 (2 directions) placed on file on 26-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 21-OCT-2011 directing that The parties' request for an extension of time to submit the draft orders pertaining to the motions to compel heard October 13 and 14, 2011 is granted until October 28, 2011 as requested placed on file on 21-OCT-2011 Confirmed in writing to the party(ies)

Letter from Defendant dated 26-OCT-2011 Re: consent of all parties to additional time to 30-NOV-2011 to exchange answers to questions ordered to be answered from the refusals motion by 31-OCT-2011. cc to all parties received on 26-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-OCT-2011 directing that a case management teleconference will take place on October 27, 2011 at 10:00 a.m. to discuss new dates for the trial in 2013 placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 21-OCT-2011 requesting an extension of time to provide the draft orders re: motions to compel heard October 13-14, 2011 (sent in pdf to the CMJ on 21-Oct-2011) received on 21-OCT-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated October 14, 2011. placed on file on 19-OCT-2011

Toronto 14-OCT-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: court will schedule a PTC:Dec 14, 2011 parties are to submit a timetable Dec 13, 2011 to cmt-ott email. held in Court Senior Usher: Sybil Mirosolin Duration per day: 14-OCT-2011 from 10:00 to 11:50 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Jacqueline Smith Total Duration: 1h 50min Appearances: Ms Jane Caskey 416-216-4000 representing Plaintiff Ms. Jordanna Sanft 416-216-4000 representing Plaintiff Mr. Christopher Tan 416-977-0888 representing Defendant Ms. Carol Hitchman 416-777-0888 representing Defendant Mr. Jerry Topolski 416-979-2211 representing Defendant Mr. David Scrimger 416-979-2211 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 229 - 230 Abstract of Hearing placed on file

Letter from counsel for PMS in T-2101-09 dated 17-OCT-2011 advising that they anticipate that some evidence of Riva will be in French received on 17-OCT-2011

Letter from GSK dated 13-OCT-2011 advising that the parties have agreed that mediation before trial is appropriate and that it may be incorporated into a scheduling order but that the parties have not yet agreed on the timing of the mediation ie before of after expert reports and asking that the timing, identity of the mediator and material for mediation be determined at the CMC in December received on 13-OCT-2011

Letter from GSK dated 12-OCT-2011 making submissions re: length of trial received on 13-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 14-OCT-2011 directing that a case management teleconference will take place on December 14, 2011 at 2:00 p.m. to discuss the timetable going forward. The parties are to file, jointly or separately, a proposed timetable by noon on December 13th, 2011 at the cmt e-mail address. placed on file on 14-OCT-2011 Confirmed in writing to the party(ies)

Toronto 13-OCT-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 63 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Sybil mirosolin Duration per day: 13-OCT-2011 from 09:30 to 04:40 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Jacqueline Smith Total Duration: 1d Appearances: Mr. Christopher Tan 416-777-0888 representing Plaintiff Mr. Keith Aguilera 416-216-4000 representing Defendant Ms. Jane Caskey 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 52 - 56 Abstract of Hearing placed on file

Toronto 21-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 50 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Sybil Mirosolin Duration per day: 21-SEP-2011 from 09:30 to 05:20 Courtroom : Courtroom No. 4-D - Toronto Court Registrar: Jacqueline Smith Total Duration: 5d Appearances: Mr. Christopher Tan 416-777-0888 representing Plaintiff Mr. Keith Aguilera 416-216-4000 representing Defendant Ms. Jordanna Sanft 416-216-4000 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 48 - 51 Abstract of Hearing placed on file

Letter from counsel for PMS in T-2101-09 on behalf of counsel for PMS in this file dated 12-OCT-2011 providing submissions re: length of trial received on 12-OCT-2011

Letter from counsel for PMS (and on behalf of PMS in T-2101-09 and Apotex in T-14-09) dated 11-OCT-2011 advising of items still remaining to be adjudicated re: motion 43(motion record doc 51) received on 11-OCT-2011

Letter from GSK dated 11-OCT-2011 attaching a list indicating 21 items remaining for the Court's adjudication re: motion 45 (motion record doc 48) received on 11-OCT-2011

Correction to General Sitting concerning Motion Doc. No. 64 Hearing added to General Sitting at Toronto on 12-DEC-2011 at 09:30 duration: 2h Language: E Reason for correction: parties agreed that matter could be heard on general sittings this day

Letter from Defendant dated 06-OCT-2011 confirming that motion doc. 64 is to be returnable for general sittings in Toronto on 12-DEC-2011 at 9:30 received on 06-OCT-2011

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of Doc. No. 64 upon Plaintiff by telecopier on 05-OCT-2011 filed on 05-OCT-2011

Notice of Motion on behalf of Defendant returnable at General Sitting in Toronto on 12-DEC-2011 to begin at 09:30 duration: 2h language: E for an order to set aside order of Prothonotary Aronovitch made during motions heard between 23-SEP-2011 and 26-SEP-2011 with respect to questions in Schedule "C", to be set aside filed on 05-OCT-2011

notice of motion in sealed envelope doc 43 on behalf of Plaintiff returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compell GSK to answer questions for examination. filed on 15-JUL-2011

SEALED NOTICE OF MOTION on behalf of Defendant returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel answers to undertakings filed on 15-JUL-2011

Copy of Order dated 28-SEP-2011 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-2101-09

E-mail on behalf of GSK attaching an amended draft order pursuant to the request of the Court at the hearing on 26-Sep-2011 placed on file on 27-SEP-2011

E-mail on behalf of GSK further to the Court's request at the hearing of September 23, 2011 attaching a draft direction to schedule a CMC on 14-Oct- 2011 following the continuation of the hearing of the motions to compel. Forwarded to the CMJ by e-mail placed on file on 26-SEP-2011

Letter from Defendant dated 19-SEP-2011 advising that its preference is that the trial in Court File No T-643-10 be heard starting April 8, 2013 together with the trial in Court File No. T-2101-09. (transmitted to the CMJ by e-mail) received on 19-SEP-2011

Letter from Defendant dated 12-SEP-2011 describing in detail what documents they are filing with regards to the hearing of the motions scheduled to be heard starting on 21-Sep-2011 received on 13-SEP-2011

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of Doc. 54, 56 and authorities upon Plaintiffs in T-14-09 and T-643-10 and Defendants in T-2101-09 by process server on 13-SEP-2011 filed on 13-SEP-2011

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of doc 54 upon Plaintiff by process server on 13-SEP-2011 filed on 13-SEP-2011

Letter from Defendant dated 13-SEP-2011 suggesting the order in which the motions to compel should be heard received on 13-SEP-2011

Solicitor's certificate of service on behalf of Christopher Tan confirming service of of doc 57 upon Defendant by personal service on 13-SEP-2011 filed on 13-SEP-2011

Covering letter from Defendant dated 12-SEP-2011 concerning explaining documents filed re: motions to compel to be heard in Toronto on 21-Sep-2011 for 5 days placed on file on 13-SEP-2011

Covering letter from Plaintiff dated 12-SEP-2011 concerning explaining documents filed re: motions to compel to be heard in Toronto starting 21-Sep-2011 for 5 days placed on file on 13-SEP-2011

Document brief of Pharmascience Inc. et al. and Apotex Inc. re: joint motion of PMS Inc. et al. in T-2101-09, Apotex in T-14-09 and Pharmascience Inc. in T-643-10 filed on 13-SEP-2011

Pharmascience's responding motion record re: defendant's motion to compel answers to questions arising out of the examination for discovery of Debby Ship filed on 13-SEP-2011

GSK's responding motion record responding to PMS' motion doc. 43 (motion record doc 51) and Apotex's motion (doc no ?)to compel GSK to Answer to questions arising out of the Examination for discovery. Only filed in the file per the direction of the Court given at the CMC on 8-Sep-2011 filed on 13-SEP-2011

Transcript of the examination for discovery of Debbie Ship, a representative of Pharmascience Inc. re: motion 45 (motion record 48)filed on behalf of the defendant filed on 13-SEP-2011

Brief of relevant documents for motion to compel doc. 45 (motion record 48) filed on behalf of Defendant Glaxo filed on 13-SEP-2011

Covering letter from Apotex dated 12-SEP-2011 concerning doc. 43,44,45 filed in T-14-09 only but relating to motions in this file and T-2101-09 placed on file on 13-SEP-2011

Ottawa 13-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the scheduling of the trial Result of Hearing: GSK is to provide a proposed schedule leading to mediation of certain aspects of these matters. GSK will advise if his client is agreable to prceeding with PMS' Section 8 in 2013 and Apotex's in 2014. If not both Section 8s will be scheduled in 2014. GSK is to advise by 19-Sep-2011. Depending on what is decided, the duration of the trials will have to be adjusted and a further CMC will be scheduled to discuss the change in duration held in chambers by way of Conference Call Duration per day: 13-SEP-2011 from 11:10 to 11:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Warren Sprigings 416-777-8888 representing Plaintiff Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-3904 representing Defendant Minutes of Hearing entered in Vol. 849 page(s) 137 - 138 Abstract of Hearing placed on file

Ottawa 08-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the upcoming hearing of the motions to compel scheduled 21-29 of September Result of Hearing: The responding parties are to serve and file their responding record by noon on September 13, 2011 (which shall include and "aide-mémoire' containing pertinent documents and exhibits and a 5 column chart as described) accompanied by a covering letter explaining the content of the material. The Court consolidated the motion material and allowed the parties to file only one set of three copies of the responding material to be placed on one of the files. The parties are to advise as to the order in which the motions to compel will be heard by September 12, 2011. held in chambers by way of Conference Call Duration per day: 08-SEP-2011 from 01:05 to 02:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Christopher Tan 416-777-0888 representing Plaintiff Jordana Sanft and Jane Caskey 416-216-4798 representing Defendant Comments: The responding motion records are to be filed in Ottawa by noon on 13-Sep- 2011 Minutes of Hearing entered in Vol. 848 page(s) 495 - 496 Abstract of Hearing placed on file

Covering letter from Defendant dated 02-SEP-2011 concerning Doc. No. 53 placed on file on 02-SEP-2011

Written Submissions on behalf of Defendant concerning in preparation for the CMC scheduled 13-Sep-2011 to discuss joint trial filed on 02-SEP-2011

Solicitor's certificate of service on behalf of CHRISTOPHER TAN confirming service of DOC 25 upon Defendant by E-MAIL on 31-AUG-2011 filed on 01-SEP-2011

Sealed envelope pursuant to Protective Order on behalf of Pharmascience Inc. purporting to contain Moving Party Motion Record Filed on 01-SEP-2011

****** CANCELLED ****** Notice of Motion contained within a Motion Record on behalf of Pharmascience Inc returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel the representatives from the Defendants to re-attend for examination for discovery filed on 01-SEP-2011

Solicitor's certificate of service on behalf of Jane E. Caskey confirming service of doc 48 upon Plaintiff by process server on 31-AUG-2011 filed on 31-AUG-2011

Sealed envelope pursuant to order dated 29-jun-2011 on behalf of Defendant purporting to contain Motion Record - discovery D S Filed on 31-AUG-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-AUG-2011 directing that the moving parties motion records re: motions to compel are to be served and filed by 31-Aug-2011 and the responding motion records are to be served and filed in Ottawa, directly to the attention of Julie Dulac, by noon, on 9-Sep-2011 placed on file on 19-AUG-2011 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 18-AUG-2011 directing that the moving parties' motion records re: motions to compel shall bes served and filed by August 31, 2011 and the moving parties' motion records by September 16, 2011 placed on file on 18-AUG-2011 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 17-AUG-2011 requesting an extension of time to file moving parties' motions records and responding motion records re: motions to compel received on 17-AUG-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 10-Aug-2011 placed on file on 10-AUG-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 10-AUG-2011 directing that the case management teleconference scheduled to take place on September 13 2011 at 2:00 p.m. will now take place at 11:00 a.m. placed on file on 10-AUG-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 10-AUG-2011 re: Apotex's status report dated 29-Jul-2011

Covering letter from Plaintiff dated 08-AUG-2011 concerning doc. no. 47 placed on file on 05-AUG-2011

Written Submissions on behalf of Plaintiff concerning implications of two separate trials and in prep for the CMC of 13-Sep-2011 filed on 05-AUG-2011

Letter from Apotex dated 29-JUL-2011 providing a quarterly status report and advising that they are meeting the timelines received on 29-JUL-2011

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of doc 45 upon Plaintiff by process server on 15-JUL-2011 filed on 15-JUL-2011

****** CANCELLED ****** Sealed envelope pursuant to Order of the Court on behalf of Defendant purporting to contain Notice of Motion (to compel answers) returnable Sept. 21-23, 26, 27, 2011 Filed on 15-JUL-2011

Solicitor's certificate of service on behalf of Christopher Tan confirming service of doc 43 upon Defendant by personal service on 15-JUL-2011 filed on 15-JUL-2011

Sealed envelope pursuant to order dated 12-jan-2011 on behalf of Plaintiff purporting to contain Notice of motion pursuant to Order dated 02-May-2011 Filed on 15-JUL-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 23-Jun-2011 placed on file on 24-JUN-2011

Communication to the Court from the Registry dated 30-JUN-2011 re: forwarding a copy of the amended protective and confidentiality order issued by Mr. Justice Campbell (appeal of the decision dated 12-Jan-2011) to the CMJ for her information

Acknowledgment of Receipt received from Plaintiff ***re-sent as original transmission was incomplete with respect to Doc. 42 placed on file on 30-JUN-2011

Letter from Plaintiff dated 29-JUN-2011 re draft order submitted Doc 42 received on 29-JUN-2011

Acknowledgment of Service received from the parties with respect to Doc 42 placed on file on 29-JUN-2011

Amended Confidentiality and Protective Order pursuant to Rule 151 rendered on 29-JUN-2011 by The Honourable Mr. Justice Campbell filed on 29-JUN-2011 Matter considered with personal appearance amending Jan 12-11 order entered in J. & O. Book, volume 1128 page(s) 93 - 103 Interlocutory Decision certified copies sent to parties

Consent on behalf of Defendant to Motion Doc 32 Draft Order filed on 29-JUN-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 24-JUN-2011 directing that the hearing of June 23, 2011 is adjourned to September 13, 2011 at 2:00 p.m. for 1.5 hours. Apotex's supplementary submissions are to be served and filed by July 22, 2011. Pharmascience's submissions are to be served and filed by August 5, 2011 and GSK's submissions by September 2, 2011 placed on file on 23-JUN-2011 Confirmed in writing to the party(ies)

Ottawa 23-JUN-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the issues re: trial as described in recent correspondence Result of Hearing: direction to follow held in chambers by way of Conference Call Duration per day: 23-JUN-2011 from 03:05 to 04:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Christopher Tan 416-777-2647 representing Plaintiff Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-3904 representing Defendant Minutes of Hearing entered in Vol. 846 page(s) 255 - 256 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 22-Jun-2011 placed on file on 23-JUN-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 22-JUN-2011 directing that a case management teleconference is scheduled on June 23, 2011 at 3:00 p.m. placed on file on 22-JUN-2011 Confirmed in writing to the party(ies)

Toronto 21-JUN-2011 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Motion Doc. No. 32 on behalf of Plaintiff Result of Hearing: Motion withdrawn on consent of counsel agreeing to a proposed Draft Order held in Court Senior Usher: Ron Cooksey Duration per day: 21-JUN-2011 from 09:30 to 11:50 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Jeff Weir Total Duration: 2h20min Appearances: Christopher Tan, Carol Hitchman (416) 777-2647 representing Plaintiff Jane Caskey, Keith Aguilera (416) 216-1899 representing Defendant Court Reporter: Calypso Schincarial, ASAP Reporting Services (416) 861-8720 21-JUN-2011 Transcript not requested Comments: Heard in conjunction with File T-2101-09. For details of minutes taken, please see File T-643-10. Minutes of Hearing entered in Vol. 846 page(s) 142 - 144 Abstract of Hearing placed on file

Memorandum to file from Julie Dulac dated 21-JUN-2011 the Court asked me to contact the parties to attempt to schedule a CMC by TC to discuss the parties' latest correspondence placed on file.

Toronto 20-JUN-2011 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Continuation of the Meeting re Motion to be heard on June 21-11 Doc 32 Result of Hearing: to be heard on June 21-11 held in Court Duration per day: 20-JUN-2011 from 12:00 to 12:40 Courtroom : Judge's Chambers - Toronto Court Registrar: Jeff Weir Total Duration: 40min Appearances: Christopher Tan, Carol Hitchman (416) 777-2647 representing Plaintiff Jane Caskey, Keith Aguilera (416) 216-3904 representing Defendant Comments: Heard in conjunction with file T-2101-09. For details of minutes taken, please see File T-643-10. Minutes of Hearing entered in Vol. 846 page(s) 82 - 85 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 14-JUN-2011 re: verbal communication bringing Glaxo's letter dated 13-Jun-2011 to the case management Prothonotary's attention

Letter from GlaxoSmithKline Inc. dated 13-JUN-2011 "...We are in receipt of the letters from counsel...dated June 3, 2011. ...GSK should not be denied its right to have this patent adjudicated upon at the earliest possible opportunity..." cc to Plaintiff received on 13-JUN-2011

Toronto 13-JUN-2011 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Meeting to discuss the progress and to see if a resolution can be found in regard to the Motion to be heard on June 21-11 Doc 32 Result of Hearing: Matter adjourned to Special Sitting in Toronto on 20-JUN-2011 to begin at 12:00 by teleconference call held by way of Conference Call in chambers Duration per day: 13-JUN-2011 from 03:00 to 03:50 Courtroom : Judge's Chambers - Toronto Court Registrar: Jeff Weir Total Duration: 50 min Appearances: Christopher Tan, Carol Hitchman (416) 777-2647 representing Plaintiff Patrick Kierans, Keith Aguilera (416) 216-3904 representing Defendant Comments: Heard in conjunction with file T-2101-09. For details of minutes taken, please see file T-643-10. Minutes of Hearing entered in Vol. 845 page(s) 377 - 379 Abstract of Hearing placed on file

Oral directions received from the Court: The Honourable Mr. Justice Campbell dated 13-JUN-2011 directing that a teleconference call take place at 3pm today (June 13-11) in regard to Doc 32 placed on file on 13-JUN-2011

Letter from Glaxo dated 08-JUN-2011 further to the instructions of the Court during the CMC on 24-May-11 advising that the parties agree that the current schedule set out in Order of May 2, 2011 does not need to be amended and will continue to govern the next steps if these actions (T-14-09, T-2101-09 and T-643-10)(provided to the Court electronically) received on 08-JUN-2011

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of Doc 39 upon Plaintiff by process server on 27-MAY-2011 filed on 27-MAY-2011

Motion Record in response to Motion Doc. No. 32 containing the following original document(s): 38 Number of copies received: 3 on behalf of the Defendant (2 vols. - same material as T-2101-09) filed on 27-MAY-2011

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 32 filed on 27-MAY-2011

Communication to the Court from the Registry dated 27-MAY-2011 re: PMS's letter dated 26-May-2011

Letter from PMS dated 26-MAY-2011 providing submissions as to why 25-to 30 days is not sufficent for the trial in this file and T-2101-09 received on 27-MAY-2011

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 26-May-2011 placed on file on 26-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-MAY-2011 directing that following the case conference of May 24, 2011, trial dates have been tentatively set aside as follows: T-2101-09 and T-643-10 - 25-30 days, in English, starting April 8, 2013, at 9:30 a.m. in Toronto. T-14-09 - 25-30 days, in English, starting January 13, 2014 at 9:30 a.m. in Toronto. Same judge as above placed on file on 26-MAY-2011 Confirmed in writing to the party(ies)

Ottawa 24-MAY-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held in chambers by way of Conference Call Duration per day: 24-MAY-2011 from 04:00 to 05:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Christopher Tan 416-777-2647 representing Plaintiff Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-4000 representing Defendant Comments: See comments in T-14-09 Minutes of Hearing entered in Vol. 844 page(s) 291 - 292 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Christopher Tan confirming service of doc 36 upon Defendant by hand on 13-MAY-2011 filed on 13-MAY-2011

Letter from Plaintiff dated 13-MAY-2011 Requesting that the material listed in this letter be available for the hearing of the motion to appeal the order of Prothonotary Aronovitch received on 13-MAY-2011

Motion Record containing the following original document(s): 32 35 Number of copies received: 3 on behalf of Plaintiff filed on 13-MAY-2011

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 32 filed on 13-MAY-2011

Letter from GSK dated 10-MAY-2011 in response to a letter from PMS in T-2101-09 and Apotex in T-14-09 received on 10-MAY-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 13-May-2011 placed on file on 13-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 13-MAY-2011 directing that "A case management teleconference is scheduled to take place on May 24, 2011 at 4:00 p.m." placed on file on 13-MAY-2011 Confirmed in writing to the party(ies)

Letter from Glaxo dated 12-MAY-2011 providing availability for CMC received on 12-MAY-2011

Letter from Pharmascience dated 12-MAY-2011 advising of its availability for a CMC received on 12-MAY-2011

****** CANCELLED ****** Letter from Counsel for Pharmascience - Carol Hitchman dated 11-MAY-2011 "Further to the direction of Prothonotary Tabib of today's date, counsel for Pharmascience is available on the following dates to attend a case management teleconference..." cc all parties received on 11-MAY-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated May 11, 2011. placed on file on 11-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 11-MAY-2011 directing that "By close of business on May 12, 2011 parties are to provide their availability for the weeks of May 16, 23 and 30, 2011 to attend a case management teleconference to discuss the scheduling of the trial." placed on file on 11-MAY-2011 Confirmed in writing to the party(ies)

Letter from Defendant dated 09-MAY-2011 in response to Mr Kieran's letter dated May 4, 2011. received on 09-MAY-2011

****** CANCELLED ****** Letter from Apotex dated 06-MAY-2011 in response to Glaxo's letter dated 4-May-2011 received on 09-MAY-2011

Communication to the Court from the Registry dated 06-MAY-2011 re: sending Glaxo's letter dated 4-May-2011 to the CMJ and the Jud. Adm.

Letter from Glaxo dated 04-MAY-2011 regarding proposed trial dates received on 04-MAY-2011

Acknowledgment of Receipt received from All parties with respect to Doc. #34 (Order from Aronovitch, P. dated May 2, 2011). placed on file on 03-MAY-2011

Order dated 02-MAY-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from "GSK" dated 08-APR-2011 Result: 1. A timetable be set for this proceeding as follows: (a) The parties shall provide the Court with a quarterly status report, the first of which to be prepared by GlaxoSmithKline Inc. by April 29, 2011. (b) The parties shall exchange answers to undertakings and questions taken under advisement and/or refused from the first round discovery by June 15, 2011. (c) The parties shall serve and file a Notice of Motion together with a schedule setting out a list of all disputed questions by July 15, 2011. (d) The parties shall meet in mid-July - mid-August 2011 to discuss the disputed questions and to narrow the questions in dispute. (e) The GlaxoSmithKline Inc. parties shall move to amend its pleadings by writing to the Court seeking an order on consent or by serving and filing a Notice of Motion to amend its pleading by July 15, 2011. (f) The parties shall provide the Court with a quarterly update report to be prepared by Apotex Inc. by July 29, 2011. (g) The motion records for the moving parties for the motions on disputed questions shall be served and filed by August 22, 2011. (h) The motion records for the responding parties for the motions on disputed questions shall be served and filed by September 7, 2011. (i) The refusal motions arising out of the first round of discovery will be heard for 4-5 days in Toronto, on September 21-23, 2011 and on September 26 and 27, 2011, if necessary. (j) The parties shall provide the Court with a quarterly update report to be prepared by Pharmascience Inc. in T-2101-09 by October 29, 2011. (k) The parties shall exchange answers to questions ordered to be answered by October 31, 2011. (l) The parties shall write to the Court by November 18, 2011 providing dates for second round discoveries of all parties' representatives, which shall be completed by January 31, 2012. (m) The parties shall write to the court by November 18, 2011 to request a case conference to be scheduled during the first 2 weeks of December 2011, to discuss the remaining pre-trial steps in these actions and set a timetable up to trial. (n) The parties shall provide the Court with a quarterly update report to be prepared by Pharmascience Inc. in T-643-10 by December 30, 2011. Filed on 02-MAY-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1122 page(s) 307 - 309 Interlocutory Decision

Communication to the Court from the Registry dated 02-MAY-2011 re: letter dated 28-Apr-2011 sent electronically to the Court

Letter from GlaxoSmithKline Inc. et al dated 28-APR-2011 We represent GlaxoSmithKline Inc. et al., and are writing on bhalf of all parties to these proceedings. We ask that this letter be brought to the attention of Madam Prothonotary Aronovitch, the case Management Judge. pursuant to the case management conference held on March 29, 2011 and draft scheduling orders filed on April 8, 2011, we are writing to provide the quarterly status report for the period ending April 29, 2011. We confirm that the first round of examinations for discovery was completed on April 4, 2011 for all parties. The parties are currently working on preparing answers to undertakings to meet the june 15, 2011 deadline as provided in the draft scheduling orders. received on 28-APR-2011

Acknowledgment of Receipt received from Grace Chang, assistant to Christopher Tan, counsel for the Plaintiff with respect to Direction issued by the Court (Lutfy, C.J.) issued April 20, 2011, by email. placed on file on 21-APR-2011

Acknowledgment of Receipt received from Mr. Keith Aguilera for the Defendant. with respect to Direction issued by the Court (Lutfy, C.J.) issued April 20, 2011, by email. placed on file on 21-APR-2011

Oral directions received from the Court: Chief Justice Lutfy dated 20-APR-2011 directing that The Plaintiff¿s motion (document #32) appealing the order of Madam Prothonotary Aronovitch dated January 12, 2011 will be heard before this Court at 180 Queen Street West, in the City of Toronto, Ontario, on Tuesday, the 21st day of June, 2011 at 9:30 in the forenoon for a duration of four (4) hours. The Plaintiff's motion record is to be served and filed no later than May 13, 2011. The Defendant's responding motion record is to be served and filed no later than May 27, 2011. placed on file on 20-APR-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-APR-2011 re: Apotex's letter dated 12-Apr-2011

****** CANCELLED ****** Letter from Apotex dated 12-APR-2011 in response to GSK's letter of 8-Apr-2011 and attaching minutes of the CMC which took place on 29-Mar-2011 received on 12-APR-2011

Communication to the Court from the Registry dated 11-APR-2011 re: the minutes of the CMC held 29-Mar-2011 and draft order re: timetable

Letter from Glaxo dated 08-APR-2011 re: the minutes of the CMC held on 29-Mar-2011 and draft order re: timetable received on 08-APR-2011

Draft Order concerning timetable further to the CMC held 29-Mar-2011 received on 08-APR-2011

Minutes of the case management conference held on 29-Mar-2011 received on 08-APR-2011

Ottawa 29-MAR-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss schedule to trial Result of Hearing: Minutes of CMC and draft order on consent to be submitted by Glaxo by 8-Apr-2011 held in Court by way of video conference Senior Usher: S. Patry Duration per day: 29-MAR-2011 from 02:10 to 04:15 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 29-MAR-2011 from 02:10 to 04:15 Courtroom : Videoconference Room - Toronto Court Registrar: Yoginder Gulia Total Duration: 2h Appearances: Warren Sprigings and Christopher Tan 416-777-0881 representing Plaintiff Jordana Sanft and Jane Caskey 416-216-4000 representing Defendant Comments: See comments in T-2101-09 Minutes of Hearing entered in Vol. 841 page(s) 63 - 64 Abstract of Hearing placed on file

Letter from Pharmascience Inc. dated 29-MAR-2011 providing the Court with their availability for the hearing of the motion Doc. 32 received on 29-MAR-2011

Communication to the Court from the Registry dated 24-MAR-2011 re: the parties' submissions dated March 21 and 22, 2011 re: assessment of length of trial etc.. in preparation for the CMC to be held 29-Mar-2011

Letter from Pharmascience Inc. dated 22-MAR-2011 providing submissions re: assessment of length of trial and timetable to trial etc.. for the CMC scheduled on 29-Mar-2011 received on 22-MAR-2011

Letter from Glaxo dated 21-MAR-2011 providing submissions re: assessment of length of trial, statement of issues etc.. for the CMC scheduled on 29-Mar-2011 received on 21-MAR-2011

Communication to the Court from the Registry dated 23-MAR-2011 re: Notice of Motion (Doc. 32)

Letter from Defendant (GlaxoSmithKline) dated 11-MAR-2011 Providing the Court with their availabilities for the scheduling of a motion pursuant to the Notice of Motion of Pharmascience Inc. et al. filed on January 24, 2011. received on 11-MAR-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-Mar-2011 placed on file on 07-MAR-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-MAR-2011 directing that the case management conference scheduled to take place on March 29, 2011 by video conference at 10:00 a.m. is now rescheduled to take place by video conference on March 29, 2011 at 2:00 p.m. for 2.5.hours placed on file on 07-MAR-2011 Confirmed in writing to the party(ies)

Letter from Glaxo dated 01-MAR-2011 further to November 2, 2010 order requesting that parties provide availability of the parties for a CMC to discuss timetables with the object of securing trial dates received on 01-MAR-2011

Letter from Plaintiff dated 01-MAR-2011 in response to court order dated 2-NOV-2010 and letter of defendant of today's date in respect of this matter and T-2101-09. The issues set out in paragraph 10 of the order will be addresses at CMC currentlt scheduled for 29_MAR-2011. received on 01-MAR-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 18-Feb-2011 placed on file on 21-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 18-FEB-2011 directing that a case conference to fix a timetable for the remainder of the proceeding and assess the length of trial for the three actions will take place, by videoconference, on March 29, 2011 for 2.5 hours commencing at 10:00 a.m. By March 22, 2011. parties are to file their assessment of the length of their own proceeding, as pleaded, by way of a statement of the issues for trial and the evidence to be adduced in respect of the issues on which they bear the burden. In addition, parties will serve and file detailed timetables up to and including the exchange of rebuttal expert evidence placed on file on 18-FEB-2011 Confirmed in writing to the party(ies)

Letter from Applicant dated 18-FEB-2011 requesting an interpreter for consecutive interpretation from French to English for an examination for dicovery that will take place on March 3,2011 starting at 9:00 am and ending at 5:00 pm at the offices of Laboratoire Riva inc. located at 660 boul. Industriel, Blainville, Québec, J7C 3V4 received on 21-FEB-2011

Communication to the Court from the Registry dated 17-FEB-2011 re: the parties' availability for an in person CMC in Toronto

E-mail from Plaintiff advising of their availability on April 14 for a CMC received on 17-FEB-2011

E-mail from Plaintiff advising of their availability for a CMC during the week of March 28 received on 10-FEB-2011

E-mail from Glaxo providing their availability for a CMC in person in Toronto on April 14 received on 17-FEB-2011

E-mail on behalf of Glaxo providing there availability for an in person CMC in Toronto for the week of March 28 received on 11-FEB-2011

Acknowledgment of Receipt received from all parties with respect to direction dated 09-Fev-2011 placed on file on 11-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 09-FEB-2011 directing that parties are to provide their availability to attend a 2 hour case conference in Toronto during the weeks of March 28 or April 14, 2011, to finalize timetables with the object of securing trial dates for the trial of the actions together or consecutively by the same judge placed on file on 09-FEB-2011 Confirmed in writing to the party(ies)

Ottawa 07-FEB-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: No direction of order is needed in this file further to this CMC held in chambers by way of Conference Call Duration per day: 07-FEB-2011 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: Warren Sprigings and Christopher Tan 416-777-0888 representing Plaintiff Carol Hitchman 416-865-8259 representing the Plaintiffs in T-2101-09 Patirck Kierans and Jordana Sanft 416-216-3904 representing Defendant Comments: The Court will issue a direction requesting the parties' availability in this file and in T-2101-09 and T-14-09 for an in person CMC to discuss the scheduling of the trial during the weeks of march 28 or April 4, 2011 Minutes of Hearing entered in Vol. 837 page(s) 257 - 258 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to direction dated 2-Feb-2011 placed on file on 03-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 02-FEB-2011 directing that a case management teleconference will take place on February 7, 2011 at 10:00 a.m. for 1 hour placed on file on 02-FEB-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 02-FEB-2011 re: the parties' correspondence dated 26-Jan-2011 and 02-Feb-2011

Letter from Mr. Tan on behalf of Ms. Hitchman (counsel for Pharmascience in T-2101-09) dated 26-JAN-2011 requesting that the direction scheduling the examinations for discoveries be amended (par 4 of the December 9, 2010 direction) received on 01-FEB-2011

Letter from Glaxo dated 31-JAN-2011 in response to Pharmascience Inc's letter dated January 26, 2011 received on 31-JAN-2011

Communication to the Court from the Registry dated 25-JAN-2011 re: letters from the parties dated January 17, 19 and 20, 2011

Letter from Pharmascience dated 20-JAN-2011 in reply to the letter from GlaxoSmithKline dated January 19, 2011 received on 20-JAN-2011

Letter from GlaxoSmithKline dated 19-JAN-2011 in response to the letter from Pharmascience dated January 17, 2011 received on 19-JAN-2011

Memorandum to file from S.Aciro dated 24-JAN-2011 Notice of Motion (Doc.32) communicated to Prothonotary Aronovitch placed on file.

Solicitor's certificate of service on behalf of CHRISTOPHER TAN confirming service of DOC.32 upon Defendant by telecopier on 24-JAN-2011 filed on 24-JAN-2011

Notice of Motion on behalf of Plaintiff (Counsel Warren Sprigings, Christopher Tan 416-777-0888) returnable (but no hearing date indicated at this time) for an appeal of the decision of Roza Aronovitch, Prothonotary dated 12-JAN-2011 Doc. No. 29 filed on 24-JAN-2011

Letter from Pharmascience dated 17-JAN-2011 providing submissions on the confidentiality order and the protective orders received on 17-JAN-2011

Acknowledgement of receipt from Mr. Tan and Mr. Aguilera of the Orders issued on January 12, 2011 placed on file on 13-JAN-2011

Affidavit of Bola Sholubi sworn on 15-DEC-2010 on behalf of Defendant in support of Motion Doc. No. 11 filed on 12-JAN-2011

Confidentiality and Protective Order Pursuant to Rule 151 dated 12-JAN-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Order dated 12-JAN-2011 Result: granted Filed on 12-JAN-2011 copies sent to parties entered in J. & O. Book, volume 1111 page(s) 30 - 39 Interlocutory Decision

Order dated 12-JAN-2011 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 11 Result: THIS COURT ORDERS that: 1. On consent, the plaintiff's motion is granted, without costs. 2. The defendant's motion is granted. 3. Costs shall be in the cause. Filed on 12-JAN-2011 copies sent to parties entered in J. & O. Book, volume 1111 page(s) 28 - 29 Interlocutory Decision

Toronto 16-DEC-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 11 on behalf of Plaintiff Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 20 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Greg Nevin Duration per day: 16-DEC-2010 from 09:30 to 14:59 Courtroom : Courtroom No. 4-B - Toronto Court Registrar: John DiDomizio Total Duration: 5h29min Appearances: Carol Hitchman / Arif Mahmood 416-906-0790 representing Plaintiff Warren Sprigings / Christopher Tan 416-777-0888 representing Plaintiff Patrick Kierans / Keith Aguilera 416-216-4000 representing Defendant Draft Decision to be submitted by Ms. Hitchman Comments: The matter was heard together with file T-2101-09. Please see T-2101-09 for complete minutes. Minutes of Hearing entered in Vol. 835 page(s) 370 - 371 Abstract of Hearing placed on file

Letter from MR. CHRISTOPHER TAN (COUNSEL FOR PLAINTIFF) dated 10-DEC-2010 RE: ORDER OF THE COURT DATED 02-NOV-2010 "...WE CONFIRM THAT THE PARTIES HAVE COMPLIED WITH THE DEADLINES SET OUT IN PARAGRAPHS 1, 3-6 AND 9 OF THE ORDER..." received on 13-DEC-2010

Acknowledgment of Receipt received from Mr. Tan & Ms. Sanft with respect to the Written Direction from Aronovitch, P. dated Dec/9/2010. placed on file on 10-DEC-2010

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 09-DEC-2010 directing that 1. The examination for discovery of GlaxoSmithKline Inc.'s ("GSK") corporate representative, Dr. Tom Krenitsky, shall be held on January 25- 27, 2011. 2. The examination for discovery of GSK's corporate representative, Ms. Cindy Roll, shall be held on February 8-9, 2011. 3. The examination for discovery of GSK's corporate representative, Mr. Norm Vojir, shall be held on March 9-10, 2011 and, only if required, March 11, 2011. 4. The examination for discovery of Pharmascience Inc. shall be held on February 22, March 1 and 8, 2011. placed on file on 09-DEC-2010 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 08-DEC-2010 Enclosing Toronto copy of Responding Motion Record filed in Ottawa on 7-DEC-2010 received on 08-DEC-2010

Covering letter from Plaintiff dated 06-DEC-2010 concerning Doc. No. 27 placed on file on 07-DEC-2010

Solicitor's certificate of service on behalf of Christopher Tan confirming service of doc 27 upon Defendant by personal service on 06-DEC-2010 filed on 07-DEC-2010

Motion Record in response to Motion Doc. No. 20 containing the following original document(s): 25 26 Number of copies received: 2 on behalf of Plaintiff filed on 07-DEC-2010

Written Representations contained within a Motion Record on behalf of Plaintiff concerning in response to motion doc 20 filed on 07-DEC-2010

Affidavit of Grace Chang sworn on 06-DEC-2010 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 20 with Exhibits A to H filed on 07-DEC-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-DEC-2010 directing that granting GSK'd request dated 2-Dec-2010 placed on file on 03-DEC-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 03-DEC-2010 re: (verbal) GSK's letter dated 2-Dec-2010

Letter from GSK dated 02-DEC-2010 on behalf of all parties requesting an extension of the deadline to file their respective responding motion records to noon December 7, 2010 in Ottawa received on 02-DEC-2010

Communication to the Court from the Registry dated 01-DEC-2010 re: GSK's letter dated 30-Nov-2010

Letter from GSK dated 30-NOV-2010 attaching a draft direction setting out the daets the parties have agreed to for the first round of examinations for discovery received on 01-DEC-2010

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 29-Nov-2010 placed on file on 30-NOV-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-NOV-2010 directing that the plaintiff's (PMS) motion for a protective order filed November 15, 2010 (doc 11 in T-643-10), the defendant's (GSK) motion for a variance to paragraph 10 of the confidentiality and protective order(doc 20 in T-643-10) and the plaintiff's (GSK) motion for a variance to paragraph 10 of the confidentiality and protective Order issued by the Court on September 29, 2010 9doc 15 in T-2101-09) will be heard, in Toronto on December 16, 2010 starting at 9:30 a.m. Responding motion records are to be served and filed in Ottawa, by noon on December 6, 2010, addressed directly to Julie Dulac. The respondent's (PMS et al's) motion for anOrder compelling the plaintiffs to provide a further and better affidavit of documents and an order compelling production of representatives (doc. 20 in T-2101-09) will be heard on December 16 only if the Court is of the view that there is sufficient time following the hearing of the above motions. The responding record is to be similarly served and filed, in Ottawa, by noon, on December 6, 2010." placed on file on 29-NOV-2010

Solicitor's certificate of service on behalf of C. KEITH AGUILERA confirming service of DOC 23 upon Plaintiff by process server on 26-NOV-2010 filed on 26-NOV-2010

Motion Record containing the following original document(s): 20 21 22 Number of copies received: 3 on behalf of Defendant filed on 26-NOV-2010

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 20 filed on 26-NOV-2010

Affidavit of Bola Sholubi sworn on 25-NOV-2010 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 20 with Exhibits A-J filed on 26-NOV-2010

Notice of Motion contained within a Motion Record on behalf of Defendant returnable (but no hearing date indicated at this time) for A VARIANCE TO PARAGRAPH 10 OF THE CONFIDENTIALITY AND PROTECTIVE ORDER PROPOSED BY PHARMASCIENCE INC IN ITS MOTION FOR CONFIDENTIALITY AND PROTECTIVE ORDER, DATED 15-NOV-2010 filed on 26-NOV-2010

Solicitor's certificate of service on behalf of C. KEITH AGUILERA confirming service of DOC 18 upon Plaintiff by process server on 26-NOV-2010 filed on 26-NOV-2010

Motion Record in response to Motion Doc. No. 11 containing the following original document(s): 16 17 Number of copies received: 3 on behalf of Defendant filed on 26-NOV-2010

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 11 filed on 26-NOV-2010

Affidavit of Bola Sholubi sworn on 25-NOV-2010 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 11 with Exhibits A-J filed on 26-NOV-2010

Communication to the Court from the Registry dated 26-NOV-2010 re: the availability of parties for the hearign of the motions re: protective order

E-mails received from both parties advising of their availability for a hearing of motions re:protective order placed on file on 25-NOV-2010

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 24-Nov-2010 placed on file on 25-NOV-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 24-NOV-2010 directing that re: correspondence dated November 22, 2010 from GSK "The motions will be set down at a special sitting of the Court. For that purpose, by November 26, 2010, parties are to provide their availability to attend a special sitting of the Court during the week of December 13, 2010, on December 20 or 22, 2010. Once the special sittng is set down, the date for the delivery of responding records will be fixed to be filed by no later than 6 days prior to the date of hearing." placed on file on 24-NOV-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 23-NOV-2010 re: GSK's letter dated 22-Nov-2010

Letter from GSK dated 22-NOV-2010 seeking directions of the Court regarding their intention to file a cross- motion and a response to motion for conf. order and file a motion to amend the conf. order in T-2101-09, suggesting that the motion and cross motion and motion in T-2101-09 be scheduled all together during the week of 13-Dec-2010 received on 22-NOV-2010

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 19-Nov-2010 placed on file on 22-NOV-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-NOV-2010 directing that " The matter is contentious and can not be determined without a formal motion. That said every effort should be made to settle the dispute without a motion through explanation and an exchange of views regarding potential prejudice and means, if any, of avoiding such while allowing for some permeability of information as necessary. If no agreement is reached by November 26, 2010, Glaxo is to serve and file its responding motion record on that date with the availability of both counsel to attend a hearing of the motion during the weeks of December 6 or 13, 2010." placed on file on 19-NOV-2010 Confirmed in writing to the party(ies)

Memorandum to file from Julie Dulac dated 19-NOV-2010 the parties have indicated that e-mailing decisions and directions is appropriate: for Pharmascience ctan@sprigings.com and warren@sprigings.com and for Glaxo pkierans@ogilvyrenault.com, jsanft@ogilvyrenault.com, dbadurina@ogilvyrenault.com and kaguilera@ogilvyrenault.com. Mr. Tan has indicated that his assistant and Mr. Sprigings assistant should be included in the e-mail and they are dzak@sprigings.com and gchang@sprigings.com placed on file.

Communication to the Court from the Registry dated 18-NOV-2010 re: re: parties correspondence dated 15-16 and 18th of November, 2010 and PMS's motion filed November 15th, 2010

Letter from Glaxo dated 16-NOV-2010 indicating that they believe that the disagreement in respect of Par 10 of the proposed protective order can be resolved in a CMC but that if the Court determines that the motion is necessary, a direction be issued re: date to file responding motion record and that it be due no less then 10 days from the direction received on 16-NOV-2010

Letter from Plaintiff dated 18-NOV-2010 This letter asks to be placed before Prothonotary Aronovitch. It responds to a letter dated Nov. 16, and respectfully submits that GSK out to file responding materials to Pharmascience's motion. received on 18-NOV-2010

Memorandum to file from Julie Dulac dated 16-NOV-2010 I spoke to Mr. Aguilera today about the defendant's letter dated 15-Nov-10 and timing of it in relation to the plaintiff's motion filed yesterday for a confidentiality order. Mr. Aguilera advised that they didn't know that the plaintiff had filed the motion when they prepared their letter which was attempting to resolve the issue without the need of a motion. Counsel for the defendant will advise if it is their intention to respond to the motion or if they want the Registry to place its November 15th letter before the Court placed on file.

Letter from GlaxoSmithKline dated 15-NOV-2010 providing the Court with a draft confidentiality Order and advising that the parties don't agree on the content of paragraph 10 received on 15-NOV-2010

Solicitor's certificate of service on behalf of Christopher Tan confirming service of Doc. 14 upon Defendant by personal service on 15-NOV-2010 filed on 15-NOV-2010

Motion Record containing the following original document(s): 11 12 13 Number of copies received: 3 on behalf of Plaintiff filed on 15-NOV-2010

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 11 filed on 15-NOV-2010

Affidavit of George Murti sworn on 15-NOV-2010 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 11 with Exhibits "A" filed on 15-NOV-2010

Notice of Motion contained within a Motion Record on behalf of Plaintiff in writing to be placed before the Court in Ottawa for an Order protecting and maintaining the confidentialityof certain documents, information and transcripts to be produced bythe parties during the course of this proceeding filed on 15-NOV-2010 Draft Order\\Judgment received.

Letter from Plaintiff dated 15-NOV-2010 enclosed is the Motion Record of Pharmascience Inc. (Motion for Confidentiality and Protective Order) which is being filed pursuant to the Order of Madame Prothonotary Aronovitch dated November 2, 2010 and also enclose a Solicitor's Cert. of Service - Christopher Tan received on 15-NOV-2010

Communication to the Court from the Registry dated 15-NOV-2010 re: Glaxo's letter dated 15-Nov-2010 re: consolidation

Letter from Glaxo dated 15-NOV-2010 advising that in light of the statement of the Court on 8-Nov-2010 to the effect that T-14-09, T-2101-09 and T-643-10 will likely be consolidated for the purpose of sequential hearing by one Judge on some common evidence they will not be bringing a motion to consolidate received on 15-NOV-2010

Proof of receipt of fax received from all parties with respect to Madam Prothonotary Aronovitch's Order dated 2-Nov-2010 placed on file on 03-NOV-2010

Communication to the Court from the Registry dated 26-OCT-2010 re: in preparation for the CMC on 26-Oct-2010

Order dated 02-NOV-2010 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. GlaxoSmithKline Inc. ("GSK") shall file a motion for consolidation or advise by way of an update as to its proposal for eventual consolidation by November 15, 2010. 2. This timetable shall be adhered to notwithstanding any motion to consolidate. 3. Any motion for a Confidentiality Order shall be served and filed or a draft Confidentiality Order for issuance on consent of the parties be submitted to the Court no later than November 15, 2010. 4. GSK shall deliver its supplementary affidavit of documents by October 26, 2010, subject to execution. 5. Pharmascience Inc. ("Pharmascience") shall provide a response to GSK's demand for particulars regarding Pharmascience's allegation of invalidity by November 12, 2010. 6. GSK shall deliver a further supplementary affidavit of documents, if required, by December 3, 2010, in light of Pharmascience's response to GSK's demand for particulars regarding Pharmascience's allegation of invalidity. 7. Pharmascience shall file a status report regarding the progress of this proceeding as against the timetable set out herein by December 10, 2010. 8. The first round of examinations for discovery shall be completed by March 31, 2011.9. Dates for the first round of examinations for discovery shall be fixed by November 30, 2010, and a draft direction setting out the dates be filed the same day for issuance by the Court. 10. By no later than March 1, 2011, the plaintiff shall request a case conference and provide the availability of counsel for both parties to attend same during the weeks of March 28 and April 4, 2011 to set a trial date for the within proceeding. Filed on 02-NOV-2010 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1104 page(s) 341 - 343 Interlocutory Decision

Communication to the Court from the Registry dated 29-OCT-2010 re: draft order rec'd 29-Oct-2010 re: CMC 26-oct-2010 forwarded electronically to the Court

Draft Order concerning CMC 26-Oct-2010 received on 29-OCT-2010

Ottawa 26-OCT-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the schedule Result of Hearing: the Plaintiff is to submit a draft order on consent by 29-Oct-2010 held in chambers by way of Conference Call Duration per day: 26-OCT-2010 from 02:00 to 02:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: Warren Sprigings and Christopher Tan 416-777-0888 representing Plaintiff Patrick Kierans and David Badurina 416-216-1904 representing Defendant Comments: P's Motion to consolidate by 15-Nov-2010 or update on what is proposed on that subject by same date. Draft confidentiality order on consent to be submitted by 15-Nov-2010 or if no consent motion by same date.P's response to demand for particulars by 12-Nov-2010. Glaxo's "further productions" by 3-Dec-2010. P to s&f status as to progress against timetable by 10-Dec-2010. Close of the 1st round of disc. by 31-Mar-2010. If the parties, by 3-Dec- 2010 advise that the examination in this file has been consolidated with the two other related files (T-2101-09 and T-14-09) the Court would be willing to extend the delay to complete 1st round of examination Minutes of Hearing entered in Vol. 832 page(s) 191 - 194 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 26-OCT-2010 re: the CMC scheduled 26-Oct-2010 at 2:00

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-OCT-2010 directing that a case management telephone conference will take place on October 26, 2010 at 2:00 p.m. placed on file on 20-OCT-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 19-OCT-2010 re: availability of parties for CMC

Letter from Glaxo dated 19-OCT-2010 providing availability for CMC received on 19-OCT-2010

Letter from Plaintiff dated 19-OCT-2010 in response to Oral directions of the court dated 15-OCT-2010. parties are available for CMC on 26-OCT-2010 in afternoon and all day on 11-NOV-2010. received on 19-OCT-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 15-OCT-2010 directing that "By no later then October 21, 2010 parties are to provide their availability to attend a case conference during the weeks of October 25 and November 8, 2010 to discuss the timetable proposed by the parties for the prosecution of this action." placed on file on 15-OCT-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-OCT-2010 re: GSK's submissions dated 8-Oct-2010 and the plaintiff's submissions dated 12-Oct-2010

****** REMOVED ****** Copy of a Letter from counsel for the plaintiff in T-14-09 dated 12-OCT-2010 in response to the Court's direction dated 29-Sep-2010 and GSK's submissions dated 8-Oct-2010 received on 12-OCT-2010

****** REMOVED ****** Copy of a Letter from counsel for the defendant in T-2101-09 dated 12-OCT-2010 in response to the Court's direction dated 29-Sep-2010 and GSK's submissions dated 08-Oct-2010 received on 12-OCT-2010

Letter from Plaintiff dated 12-OCT-2010 This letter requests to be placed before Prothonotary Aronovitch, and to have a case conference. They also outline a possible timetable for a possible schedule. received on 12-OCT-2010

Letter from GSK dated 08-OCT-2010 providing a proposed timetable further to the direction of the Court dated 29-Sep-2010 received on 08-OCT-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-SEP-2010 directing that "The discussions with respect to consolidation if any, of these files is not meant to effect a stay of these proceedings. By October 8, 2010, GSK is to file a status report on each of these files and propose a timetable or amendments to an existing timetable for each. If not on consent, parties opposite are to respond by October 12, 2010 and request case conferences which will be held separately in any file where there is no consent to a timetable." placed on file on 29-SEP-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-SEP-2010 re: counsel's correspondence dated Sept 3 and 7, 2010

****** CANCELLED ****** Communication to the Court from the Registry dated 10-SEP-2010 re: re: the correspondence from the parties dated 3-Sep-2010 and 7-Sep-2010

****** REMOVED ****** Letter from the plaintiff in T-14-09 (Apotex) dated 07-SEP-2010 in response to GSK's letter dated 3-Sep-2010 received on 07-SEP-2010

****** REMOVED ****** Letter from defendants in T-2101-09 dated 07-SEP-2010 in response to GSK's letter dated September 3, 2010 received on 07-SEP-2010

Letter from GSK dated 03-SEP-2010 Requesting the Court an extension on time until September 30, 2010 to comply with the Direction of Madam Aronovitch dated July 23, 2010. received on 03-SEP-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-AUG-2010 directing that Further to Ms. Sanft's letter dated August 27, 2010, requesting until September 9, 2010 to report on discussions regarding consolidation: "Granted" placed on file on 30-AUG-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 30-AUG-2010 re: GSK's letter dated 27-Aug-2010

Letter from GSK dated 27-AUG-2010 requesting an extension until September 9, 2010 to comply with the July 23, 2010 direction received on 27-AUG-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 23-JUL-2010 directing that "By the end of August 2010, the parties are to meet to see if they can find common ground with respect to any consolidation of the three actions at any point in the proceedings. By September 3, 2010 Mr. Kierans is to advise the Court as to any consensus by the parties' and in the alternative provide a date by which he will be serving and filing a motion to consolidate if any placed on file on 23-JUL-2010 Confirmed in writing to the party(ies)

Ottawa 22-JUL-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss consolidation for trial Result of Hearing: Direction to follow held by way of video conference Senior Usher: p. Gendron Duration per day: 22-JUL-2010 from 02:08 to 02:30 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 1.5h Appearances: Warren Sprigings and Christopher Tan 416-777-0888 representing Pharmascience Inc. Patrick Kierans, Jordana Sanft and Keith Aguilera 416-216-4000 representing GSK Comments: heard with T-2101-09 and T-14-09 Minutes of Hearing entered in Vol. 827 page(s) 436 - 437 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of submissions dated 12-Jul-2010 by GSK upon all parties by telecopier on 12-JUL-2010 filed on 12-JUL-2010

Communication to the Court from the Registry dated 19-JUL-2010 re: in preparation for the CMC on 22-Jul-2010

****** REMOVED ****** Letter from the defendant in T-2101-09 on behalf of Pharmascience in this file dated 12-JUL-2010 in response to the Court's direction dated 10-Jun-2010 received on 12-JUL-2010

Letter from GSK Inc. dated 12-JUL-2010 in response to the Court's direction dated 10-Jun-2010 received on 12-JUL-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 12-JUL-2010 directing that Accept the document submitted on July 12, 2010 for filing placed on file on 12-JUL-2010

****** REMOVED ****** Letter from Apotex Inc. (Plaintiff in T-14-09) dated 12-JUL-2010 This letter is responding to the direction issued 10-JUN-2010. received on 12-JUL-2010

Communication to the Court from the Registry dated 05-JUL-2010 re: GSK's letter dated 30-Jun-2010

Memorandum to file from Julie Dulac dated 05-JUL-2010 further to the receipt of counsel for GSK's letter dated 30-Jun-2010, I advised the parties that Madam Aronovitch is away until July 12, 2010 and that the correspondence will be placed before her upon her return and that in case of a request to vary a timeline, if the parties are able to agree, they are to abide by the agreed timetable as if she had endorsed it. The Order or direction will be issued upon her return placed on file.

Letter from GSK dated 30-JUN-2010 requesting an extension of time, on consent, to provide the Court with submissions with regards to consolidation until July 12, 2010 received on 30-JUN-2010

Communication to the Court from the Registry dated 24-JUN-2010 re: Order of the Court dated June 10, 2010

Order dated 10-JUN-2010 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Directions of the Court dated 10-JUN-2010 Result: Pursuant to Rule 383 that Prothonotary Roza Aronovitch is assigned as Case Management Judge in this matter. Filed on 11-JUN-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1092 page(s) 85 - 85 Interlocutory Decision

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 10-JUN-2010 directing that "A case management conference by video conference will take place on July 22, 2010 commencing at 2:00 p.m. for 1.5 hours. For that purpose, by July 5, 2010, parties are to serve and file a statement of the issues for the trial in their proceeding; advantages and economies that might be realized by consolidating the hearings and impediments or problems, if any, to overcome." placed on file on 10-JUN-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 09-JUN-2010 re: counsel for GSK's letter dated June 4, 2010

Copy of direction of Madam Prothonotary Aronovitch dated May 27, 2010 given in T-2101-09 and T-14-09 directing that: "In light of the correspondence dated May 25, 2010 from Ms. Hitchman.....As counsel in T-643-10 ought to be included in teh consolidation discussion, the plaintiff is requested, by June 4, 2010 to file the dates of availability of all counsel during the weeks of July 12 and 19, 2010." placed on file on 27-MAY-2010

Letter from GSK dated 04-JUN-2010 in response the the May 27th, 2010 direction providing their availability for a CMC received on 04-JUN-2010

Covering letter from Plaintiff dated 28-MAY-2010 concerning Doc. Nos. 5 6 7 placed on file on 28-MAY-2010

Solicitor's certificate of service on behalf of Christopher Tan confirming service of Doc. 6 upon Defendant by telecopier on 28-MAY-2010 filed on 28-MAY-2010

Reply on behalf of Plaintiff Filed on 28-MAY-2010

Consent on behalf of all parties to an extension of time for an additional 5 days for the Plaintiff to file a Reply filed on 28-MAY-2010

****** CANCELLED ****** Communication to the Court from the Registry dated 27-MAY-2010 re: availablity of parties for a CMC re: cons. and trial dates and paragraph 1 (a) of the May 18th Order needed an amendment and July 20th hearing date not needed anymore and the request for T-643-10 to be case managed with this file and T-14-09.

****** CANCELLED ****** E-mail from counsel for the defendants advising of her availability for a CMC re: consolidation and trial dates placed on file on 27-MAY-2010

Communication to the Court from the Registry dated 26-MAY-2010 re: to the Judicial Administrator requesting that Madam Aronovitch be designated as the CMJ

Letter from Defendant dated 21-MAY-2010 requesting that Madam Prothonotary Aronovitch be designated as the CMJ in this matter as she is case managing two other related files (T-2101-09 and T-14-09) received on 21-MAY-2010

Solicitor's certificate of service on behalf of David Badurina confirming service of Doc. No. 3 upon Plaintiff by personal service on 13-MAY-2010 filed on 13-MAY-2010

Defence filed on 13-MAY-2010

Affidavit of service of MIKE GALLANT sworn on 06-MAY-2010 on behalf of Plaintiff confirming service of DOC 1 upon Defendant by personal service on 28-APR-2010 with Exhibits A filed on 06-MAY-2010

Covering letter from Plaintiff dated 23-APR-2010 concerning Doc. No. 1 placed on file on 23-APR-2010

Statement of Claim filed on 23-APR-2010 Tariff other action - $150.00